<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated using Ez-XBRL version 6.0.1.3 [04/27/2013 09:11:54 PM] by DataTracks -->
<!-- Based on XBRL 2.1 -->
<!--XBRL Document Modified with Ez-Editor Version 1.0.2.9 by DataTracks on Wednesday, May 08, 2013 12:06:35 AM -->
<xbrli:xbrl xmlns:bcli="http://www.brainstorm-cell.com/20130331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="bcli-20130331.xsd"/>
<!-- Context Section  -->
<xbrli:context id="Context_As_Of_21-Sep-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Sep-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_31-Mar-2001">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2001-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2001-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2001-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2001-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2001-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2001">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2002">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-04-01
</xbrli:startDate>
<xbrli:endDate>
2002-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-04-01
</xbrli:startDate>
<xbrli:endDate>
2002-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-04-01
</xbrli:startDate>
<xbrli:endDate>
2002-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-04-01
</xbrli:startDate>
<xbrli:endDate>
2002-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-04-01
</xbrli:startDate>
<xbrli:endDate>
2002-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2002">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2003">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-04-01
</xbrli:startDate>
<xbrli:endDate>
2003-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-04-01
</xbrli:startDate>
<xbrli:endDate>
2003-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-04-01
</xbrli:startDate>
<xbrli:endDate>
2003-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-04-01
</xbrli:startDate>
<xbrli:endDate>
2003-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-04-01
</xbrli:startDate>
<xbrli:endDate>
2003-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2003">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-04-01
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-04-01
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-04-01
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-04-01
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-04-01
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Mar-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-09-23
</xbrli:startDate>
<xbrli:endDate>
2004-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-May-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-05-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21-May-2004_StatementClassOfStockAxis_PurchaseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcli:PurchaseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-05-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2004_ProductOrServiceAxis_FilingServiceMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:FilingServiceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-06-01
</xbrli:startDate>
<xbrli:endDate>
2004-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2004_RangeAxis_MaximumMember_ProductOrServiceAxis_FilingServiceMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:FilingServiceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-06-01
</xbrli:startDate>
<xbrli:endDate>
2004-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2004_RangeAxis_MinimumMember_ProductOrServiceAxis_FilingServiceMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:FilingServiceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-06-01
</xbrli:startDate>
<xbrli:endDate>
2004-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2004_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:GlobalShareOptionPlan2004Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EldadMelamedAndDanielOffenConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-02-01
</xbrli:startDate>
<xbrli:endDate>
2005-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-02-01
</xbrli:startDate>
<xbrli:endDate>
2005-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2005">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-04-01
</xbrli:startDate>
<xbrli:endDate>
2005-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-04-01
</xbrli:startDate>
<xbrli:endDate>
2005-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-04-01
</xbrli:startDate>
<xbrli:endDate>
2005-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-04-01
</xbrli:startDate>
<xbrli:endDate>
2005-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-04-01
</xbrli:startDate>
<xbrli:endDate>
2005-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2005">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-03-01
</xbrli:startDate>
<xbrli:endDate>
2005-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ScientificAdvisoryBoardOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-03-01
</xbrli:startDate>
<xbrli:endDate>
2005-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ScientificAdvisoryBoardTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-03-01
</xbrli:startDate>
<xbrli:endDate>
2005-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardThreeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ScientificAdvisoryBoardThreeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-03-01
</xbrli:startDate>
<xbrli:endDate>
2005-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardFourMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:USStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ScientificAdvisoryBoardFourMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-03-01
</xbrli:startDate>
<xbrli:endDate>
2005-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-08-01
</xbrli:startDate>
<xbrli:endDate>
2005-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Sep-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-09-01
</xbrli:startDate>
<xbrli:endDate>
2005-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-12-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2006_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EmployeeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-06-01
</xbrli:startDate>
<xbrli:endDate>
2006-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2006_RangeAxis_MaximumMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EmployeeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-06-01
</xbrli:startDate>
<xbrli:endDate>
2006-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2006_RangeAxis_MinimumMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EmployeeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-06-01
</xbrli:startDate>
<xbrli:endDate>
2006-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_31-Dec-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-04-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_05-Mar-2007_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConvertiblePromissoryNoteToThirdPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-03-05
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_30-Apr-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-05-01
</xbrli:startDate>
<xbrli:endDate>
2007-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-07-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2007">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-07-01
</xbrli:startDate>
<xbrli:endDate>
2007-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-07-01
</xbrli:startDate>
<xbrli:endDate>
2007-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:DirectorOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-07-01
</xbrli:startDate>
<xbrli:endDate>
2007-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedOneMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-07-01
</xbrli:startDate>
<xbrli:endDate>
2007-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedTwoMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-07-01
</xbrli:startDate>
<xbrli:endDate>
2007-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Oct-2007_ProductOrServiceAxis_ScientificAdvisoryBoardMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ScientificAdvisoryBoardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-10-01
</xbrli:startDate>
<xbrli:endDate>
2007-10-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-10-01
</xbrli:startDate>
<xbrli:endDate>
2007-10-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2007">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2007">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_20-May-2008_ProductOrServiceAxis_FinancialAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:FinancialAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-05-01
</xbrli:startDate>
<xbrli:endDate>
2008-05-20
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-08-01
</xbrli:startDate>
<xbrli:endDate>
2008-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Nov-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-11-01
</xbrli:startDate>
<xbrli:endDate>
2008-11-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2008_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2008">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_05-Apr-2009_ProductOrServiceAxis_ChiefTechnologyAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ChiefTechnologyAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-04-05
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2009_ProductOrServiceAxis_ChiefTechnologyAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ChiefTechnologyAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-04-01
</xbrli:startDate>
<xbrli:endDate>
2009-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-06-01
</xbrli:startDate>
<xbrli:endDate>
2009-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefFinancialOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefFinancialOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-06-01
</xbrli:startDate>
<xbrli:endDate>
2009-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-10-01
</xbrli:startDate>
<xbrli:endDate>
2009-10-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-10-01
</xbrli:startDate>
<xbrli:endDate>
2009-10-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_13-Dec-2009_ProductOrServiceAxis_ConvertiblePromissoryNoteToLegalAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConvertiblePromissoryNoteToLegalAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-13
</xbrli:instant>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_As_Of_24-Dec-2009_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InitialResearchPeriodMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:InitialResearchPeriodMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24-Dec-2009_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ExtendedResearchPeriodMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:ExtendedResearchPeriodMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2009">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2009">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2009_ProductOrServiceAxis_ServiceProviderMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_27-Jan-2010_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConvertiblePromissoryNoteToThirdPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-01-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_27-Jan-2010_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConvertiblePromissoryNoteToThirdPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-01-27
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jan-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jan-2010_ProductOrServiceAxis_ServiceProviderMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jan-2010_ProductOrServiceAxis_PublicRelationsAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:PublicRelationsAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-02-01
</xbrli:startDate>
<xbrli:endDate>
2010-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2010_ProductOrServiceAxis_LegalAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:LegalAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-02-01
</xbrli:startDate>
<xbrli:endDate>
2010-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:InvestorOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-02-01
</xbrli:startDate>
<xbrli:endDate>
2010-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:InvestorTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-02-01
</xbrli:startDate>
<xbrli:endDate>
2010-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorThreeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:InvestorThreeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-02-01
</xbrli:startDate>
<xbrli:endDate>
2010-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrIsraeliMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfMelamedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ProfMelamedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-May-2010_AwardTypeAxis_RestrictedStockMember_ProductOrServiceAxis_PublicRelationsAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:PublicRelationsAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-05-01
</xbrli:startDate>
<xbrli:endDate>
2010-05-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ManagementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ManagementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-05-01
</xbrli:startDate>
<xbrli:endDate>
2010-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EldadMelamedAndDanielOffenConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_RangeAxis_MaximumMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_RangeAxis_MinimumMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_RangeAxis_MinimumMember_StatementEquityComponentsAxis_WarrantIssuedOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2010_RangeAxis_MaximumMember_StatementEquityComponentsAxis_WarrantIssuedOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:EldadMelamedAndDanielOffenConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:DirectorOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2010_ProductOrServiceAxis_ServiceProviderMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ScientificBoardMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ScientificBoardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Dec-2010_ProductOrServiceAxis_ConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Jan-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jan-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jan-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_Custom_28-Feb-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedOneMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:WarrantIssuedTwoMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_ProductOrServiceAxis_LegalAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:LegalAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_CashAndCashEquivalentsAxis_CashMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-02-01
</xbrli:startDate>
<xbrli:endDate>
2011-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_As_Of_31-Mar-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Mar-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-03-01
</xbrli:startDate>
<xbrli:endDate>
2011-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Mar-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_CashAndCashEquivalentsAxis_CashMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-03-01
</xbrli:startDate>
<xbrli:endDate>
2011-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30-Jun-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:DirectorOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ServiceProviderMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_ProductOrServiceAxis_LegalAdvisorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:LegalAdvisorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrIsraeliMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-06-01
</xbrli:startDate>
<xbrli:endDate>
2011-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_25-Jul-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-07-25
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-07-01
</xbrli:startDate>
<xbrli:endDate>
2011-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-08-01
</xbrli:startDate>
<xbrli:endDate>
2011-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrSchorMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrSchorMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-08-01
</xbrli:startDate>
<xbrli:endDate>
2011-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ScientificBoardMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ScientificBoardMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-08-01
</xbrli:startDate>
<xbrli:endDate>
2011-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrSchorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrSchorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-08-01
</xbrli:startDate>
<xbrli:endDate>
2011-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerDirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerDirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-11-01
</xbrli:startDate>
<xbrli:endDate>
2011-11-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>




<xbrli:context id="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_BoardMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:BoardMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-11-01
</xbrli:startDate>
<xbrli:endDate>
2011-11-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_FYE_31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bcli:RelatedPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_AwardTypeAxis_RestrictedStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ProfDanielOffenConsultantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_AwardTypeAxis_EnrollmentOfOneThirdOfPatientsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bcli:EnrollmentOfOneThirdOfPatientsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_AwardTypeAxis_EnrollmentOfAllPatientsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bcli:EnrollmentOfAllPatientsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2011_AwardTypeAxis_CompletionOfStudyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bcli:CompletionOfStudyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:TotalStockBasedCompensationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:InterestExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrIsraeliMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_17-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_LeaderUnderwriters1993LtdMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bcli:LeaderUnderwriters1993LtdMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-01
</xbrli:startDate>
<xbrli:endDate>
2012-07-17
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bcli:PublicOfferingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-07-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-01
</xbrli:startDate>
<xbrli:endDate>
2012-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bcli:PublicOfferingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-01
</xbrli:startDate>
<xbrli:endDate>
2012-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_30-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-01
</xbrli:startDate>
<xbrli:endDate>
2012-08-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ManagementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ManagementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-01
</xbrli:startDate>
<xbrli:endDate>
2012-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-01
</xbrli:startDate>
<xbrli:endDate>
2012-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">bcli:GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrIsraeliMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ProfDanielOffenConsultantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ConsultantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-02-01
</xbrli:startDate>
<xbrli:endDate>
2013-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>



<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:TotalStockBasedCompensationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:InterestExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ChiefExecutiveOfficerOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateNovDec2004Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2006Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateMar2007Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2008Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateAprOct2009Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJan2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJan2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApril2012Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2013Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateNovDec2004Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2006Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateMar2007Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2008Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateAprOct2009Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateNovDec2004Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2006Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateMar2007Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2008Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateAprOct2009Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_31-Mar-2013_SubsequentEventTypeAxis_SubsequentEventMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorsAndAdvisoryBoardMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:DirectorsAndAdvisoryBoardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateNovDec2004Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFebDec2006Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateMar2007Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2008Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateAprOct2009Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJan2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2010TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2010Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJan2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2011TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApr2011Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateApril2012Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012OneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateJuly2012TwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">bcli:IssuanceDateFeb2013Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_157ME_31-Mar-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2000-09-23</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>

<xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2000-09-23</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>

<xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2000-09-23</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>

<xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:TotalStockBasedCompensationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2000-09-23</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>

<xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">bcli:InterestExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2000-09-23</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_As_Of_22-Sep-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-22
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-22
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-22
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-22
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-09-22
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>XUI~\FVPYwivc444c555cT{h>6<HE<4GG1FH<:18F651FFH;1:=H5=G<6G96I -->
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_3ME_31-Mar-2013">BRAINSTORM CELL THERAPEUTICS INC.</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_3ME_31-Mar-2013">0001137883</dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate contextRef="Context_3ME_31-Mar-2013">--12-31</dei:CurrentFiscalYearEndDate>
<dei:EntityFilerCategory contextRef="Context_3ME_31-Mar-2013">Smaller Reporting Company</dei:EntityFilerCategory>
<dei:TradingSymbol contextRef="Context_3ME_31-Mar-2013">bcli</dei:TradingSymbol>
<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of_06-May-2013" unitRef="shares" decimals="0">152714176</dei:EntityCommonStockSharesOutstanding>
<dei:DocumentType contextRef="Context_3ME_31-Mar-2013">10-Q</dei:DocumentType>
<dei:AmendmentFlag contextRef="Context_3ME_31-Mar-2013">false</dei:AmendmentFlag>
<dei:DocumentPeriodEndDate contextRef="Context_3ME_31-Mar-2013">2013-03-31</dei:DocumentPeriodEndDate>
<dei:DocumentFiscalPeriodFocus contextRef="Context_3ME_31-Mar-2013">Q1</dei:DocumentFiscalPeriodFocus>
<dei:DocumentFiscalYearFocus contextRef="Context_3ME_31-Mar-2013">2013</dei:DocumentFiscalYearFocus>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_21-Sep-2000" unitRef="USD" decimals="-3" id="Footnote-1_1">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_24-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="-3">1000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="-3">93000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Mar-2011" unitRef="USD" decimals="-3">3664000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30-Jun-2011" unitRef="USD" decimals="-3">2899000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30-Jun-2012" unitRef="USD" decimals="-3">843000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">1317000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_2">1868000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_22-Sep-2000" unitRef="USD" decimals="-3" id="Footnote-1_3">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1923000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">1145000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:ShortTermInvestments contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">2769000</us-gaap:ShortTermInvestments>
<us-gaap:ShortTermInvestments contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">1772000</us-gaap:ShortTermInvestments>
<us-gaap:NontradeReceivablesCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">742000</us-gaap:NontradeReceivablesCurrent>
<us-gaap:NontradeReceivablesCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">617000</us-gaap:NontradeReceivablesCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">46000</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">43000</us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">4874000</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">4300000</us-gaap:AssetsCurrent>
<us-gaap:PrepaidExpenseNoncurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">17000</us-gaap:PrepaidExpenseNoncurrent>
<us-gaap:PrepaidExpenseNoncurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">23000</us-gaap:PrepaidExpenseNoncurrent>
<bcli:SeverancePayFund contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">172000</bcli:SeverancePayFund>
<bcli:SeverancePayFund contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">195000</bcli:SeverancePayFund>
<us-gaap:LongTermInvestments contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">189000</us-gaap:LongTermInvestments>
<us-gaap:LongTermInvestments contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">218000</us-gaap:LongTermInvestments>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">247000</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">234000</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:Assets contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">5310000</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">4752000</us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">358000</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">246000</us-gaap:AccountsPayableCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">605000</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">656000</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableOtherCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">176000</us-gaap:AccountsPayableOtherCurrent>
<us-gaap:AccountsPayableOtherCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">159000</us-gaap:AccountsPayableOtherCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">1139000</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">1061000</us-gaap:LiabilitiesCurrent>
<us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">189000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
<us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">210000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
<us-gaap:Liabilities contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">1328000</us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">1271000</us-gaap:Liabilities>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">7000</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">7000</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">51483000</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">52064000</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">47508000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">48590000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_21-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_24-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_24-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001" unitRef="USD" decimals="-3">68000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">84000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-17000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002" unitRef="USD" decimals="-3">53000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">95000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-43000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003" unitRef="USD" decimals="-3">21000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">110000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-90000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004" unitRef="USD" decimals="-3">-31000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">131000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-163000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005" unitRef="USD" decimals="-3">704000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">25101000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-5395000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-19003000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006" unitRef="USD" decimals="-3">-7911000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15803000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-1395000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-22320000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006" unitRef="USD" decimals="-3">-1816000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">24427000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-26244000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007" unitRef="USD" decimals="-3">-2428000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">2000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">30058000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-32488000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008" unitRef="USD" decimals="-3">-2076000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">3000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">33881000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-35960000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="-3">-1743000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">4000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">35994000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-37741000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="-3">-459000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">5000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">39696000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-40160000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">3982000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">3481000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1488000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">6000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">45560000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-44078000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">7000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">51483000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-47508000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">7000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">52064000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-48590000</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31-Dec-2012" unitRef="USD" decimals="-3">5310000</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">4752000</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD_per_Share" decimals="5">0.00005</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Dec-2012" unitRef="USD_per_Share" decimals="5">0.00005</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Mar-2013" unitRef="USD_per_Share" decimals="5">0.00005</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31-Dec-2012" unitRef="shares" decimals="0">800000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">800000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_21-May-2004_StatementClassOfStockAxis_PurchaseAgreementMember" unitRef="shares" decimals="0">10238000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31-Dec-2012" unitRef="shares" decimals="0">150085035</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">151854176</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_21-May-2004_StatementClassOfStockAxis_PurchaseAgreementMember" unitRef="shares" decimals="0">10238000</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31-Dec-2012" unitRef="shares" decimals="0">150085035</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">151854176</us-gaap:CommonStockSharesOutstanding>


<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">369000</us-gaap:ResearchAndDevelopmentExpense>

<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">522000</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-3_1">26711000</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">510000</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">559000</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-4_1">19310000</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">879000</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">1081000</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-5_1">46021000</us-gaap:OperatingExpenses>
<us-gaap:InterestExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-11000</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">1000</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-6_1">2455000</us-gaap:InterestExpense>
<us-gaap:OtherNonoperatingIncome contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:OtherNonoperatingIncome>
<us-gaap:OtherNonoperatingIncome contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:OtherNonoperatingIncome>
<us-gaap:OtherNonoperatingIncome contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-7_1">132000</us-gaap:OtherNonoperatingIncome>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-868000</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-1082000</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-8_1">-48344000</us-gaap:OperatingIncomeLoss>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">4000</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-9_1">82000</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-872000</us-gaap:IncomeLossFromContinuingOperations>
<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-1082000</us-gaap:IncomeLossFromContinuingOperations>
<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-10_1">-48426000</us-gaap:IncomeLossFromContinuingOperations>
<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-11_1">-164000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">-17000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-17000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002" unitRef="USD" decimals="-3">-26000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-26000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003" unitRef="USD" decimals="-3">-47000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-47000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">-73000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-73000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">-18840000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-18840000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">-3317000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-3317000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">-3924000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-3924000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">-6244000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-6244000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">-3472000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-3472000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">-1781000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-1781000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">-2419000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-2419000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">-3918000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-3918000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-872000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">-3430000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-3430000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-1082000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">-1082000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-12_1">-48590000</us-gaap:NetIncomeLoss>
<us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="Context_3ME_31-Mar-2012" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
<us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="Context_3ME_31-Mar-2013" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_31-Mar-2012" unitRef="shares" decimals="0">126591262</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">150953117</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_21-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">0</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10100000</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10100000</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10100000</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10238000</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">20867808</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">22854587</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">24201812</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">41004409</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">55241418</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">76309152</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">95832978</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">0</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">126444309</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">150085035</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">151854176</us-gaap:SharesOutstanding>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">17506000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_1">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">17506000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">662000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_2">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">662000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">453000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">453000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">1446000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1446000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">33000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">33000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">775000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">775000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">96000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_4">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">96000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">449000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">449000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">195000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">195000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">98000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">98000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2025000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">934904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1147225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">544095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">5284284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">443333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">474203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">794423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">809696</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">5979000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-5979000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_5">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">486000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-486000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">1168000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_6">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1168000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">1232000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_7">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1232000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">731000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">731000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">409000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">409000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">388000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_8">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">388000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">1135000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1135000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">560000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">560000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">203000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">203000</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockbasedCompensationRelatedToOptionsGrantedToEmployeesValue>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">466667</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2025040</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">885000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesShares>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_9">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">140000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">140000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">402385</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">755594</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">150000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_10">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">32000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefFinancialOfficerMember" unitRef="USD" decimals="-3">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_11">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_Custom_28-Feb-2011_ProductOrServiceAxis_LegalAdvisorMember" unitRef="USD" decimals="-3">137000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">243000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">243000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">137000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_12">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">137000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>






<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">17399</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1540885</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">946834</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1648728</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">483333</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1182606</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="shares" decimals="0">14396010</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="shares" decimals="0">173000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="shares" decimals="0">727696</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member" unitRef="shares" decimals="0">125000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="shares" decimals="0">946834</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">214000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_13">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">214000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_14">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_15">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">11000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_16">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">272000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">272000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">9000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_17">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">9000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>






<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">3832621</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1860000</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">3366783</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">3929446</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1046834</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">959729</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">3602000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3601000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">5023000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">5022000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">250000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">250000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
<bcli:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">14160933</bcli:StockIssuedDuringPeriodSharesPrivatePlacement>
<bcli:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="Context_FYE_31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">19818968</bcli:StockIssuedDuringPeriodSharesPrivatePlacement>
<bcli:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">833334</bcli:StockIssuedDuringPeriodSharesPrivatePlacement>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_18">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2000001</bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10499999</bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares>
<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">17000</bcli:StockIssuedDuringPeriodForCashInSeptember>
<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForCashInSeptember>
<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">16000</bcli:StockIssuedDuringPeriodForCashInSeptember>
<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInSeptember>
<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInSeptember>
<bcli:StockIssuedDuringPeriodForCashSharesInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">8500000</bcli:StockIssuedDuringPeriodForCashSharesInSeptember>
<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForCashInMarch>
<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_19">0</bcli:StockIssuedDuringPeriodForCashInMarch>
<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForCashInMarch>
<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInMarch>
<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInMarch>
<bcli:StockIssuedDuringPeriodForCashSharesInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1600000</bcli:StockIssuedDuringPeriodForCashSharesInMarch>
<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_20">0</bcli:StockIssuedDuringPeriodValueStockSplits>
<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
<us-gaap:StockIssuedDuringPeriodSharesStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">10100000</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">6000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_21">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">6000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_22">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3" id="Footnote-2_23">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_24">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
<bcli:StockCancelledDuringPeriodShares contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">-10062000</bcli:StockCancelledDuringPeriodShares>
<bcli:StockCancelledDuringPeriodShares contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">-1800000</bcli:StockCancelledDuringPeriodShares>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_25">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">8510000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJune>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">8000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">8000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_26">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">7000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">7000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">1418000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_27">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1418000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">2000000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1999000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">1500000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1499000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">1751000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1750000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1894808</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">11500000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">8625000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">9916667</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">7250000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">584000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">584000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">1174000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">51000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">1123000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">149000</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_28">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">149000</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">186875</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInMay>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">99000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_29">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">99000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">165000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJuly>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">225000</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_30">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">225000</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">312500</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInSeptember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_31">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">187500</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInDecember>
<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-3363000</bcli:ForfeitureOfOptionsGrantedToEmployees>
<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">3363000</bcli:ForfeitureOfOptionsGrantedToEmployees>
<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">-7906000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-7906000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">7191000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">7191000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">164000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">164000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">1086000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1086000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">407000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">407000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<bcli:EliminationOfDeferredStockCompensationDueToImplementation contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensationDueToImplementation>
<bcli:EliminationOfDeferredStockCompensationDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensationDueToImplementation>
<bcli:EliminationOfDeferredStockCompensationDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-1395000</bcli:EliminationOfDeferredStockCompensationDueToImplementation>
<bcli:EliminationOfDeferredStockCompensationDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">1395000</bcli:EliminationOfDeferredStockCompensationDueToImplementation>
<bcli:EliminationOfDeferredStockCompensationDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensationDueToImplementation>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">109000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">109000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">110000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">110000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">224000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_32">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">224000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">1276000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_33">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1276000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">200000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_34">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">200000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">189000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Footnote-2_35">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">189000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">30000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">30000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">725881</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">3644610</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2500000</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1016109</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_3ME_31-Mar-2013_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">126111</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_31-Jul-2007" unitRef="USD" decimals="-6">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_31-Jul-2012" unitRef="USD" decimals="-5">4900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-5">5700000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Jun-2004_RangeAxis_MaximumMember_ProductOrServiceAxis_FilingServiceMember" unitRef="shares" decimals="0">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Jun-2004_RangeAxis_MinimumMember_ProductOrServiceAxis_FilingServiceMember" unitRef="shares" decimals="0">40000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_31-Dec-2004_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">8861875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember" unitRef="shares" decimals="0">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardOneMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardTwoMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardThreeMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember_ProductOrServiceAxis_ScientificAdvisoryBoardFourMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">8861875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_30-Apr-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">41666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Aug-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">960000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorOneMember" unitRef="shares" decimals="0">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorTwoMember" unitRef="shares" decimals="0">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorThreeMember" unitRef="shares" decimals="0">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-May-2010_AwardTypeAxis_RestrictedStockMember_ProductOrServiceAxis_PublicRelationsAdvisorMember" unitRef="shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Jun-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ManagementMember" unitRef="shares" decimals="0">800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2475000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ScientificBoardMember" unitRef="shares" decimals="0">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">833333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">12815000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">476666</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrSchorMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">923374</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ScientificBoardMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_BoardMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerDirectorMember" unitRef="shares" decimals="0">250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember" unitRef="shares" decimals="0">1250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">19818968</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">201000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">201000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">281000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">281000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">729000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">729000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">455000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">455000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
<bcli:StockIssuedDuringPeriodForCashInSeptemberPricePerShare contextRef="Context_6ME_31-Mar-2001" unitRef="USD_per_Share" decimals="5">0.00188</bcli:StockIssuedDuringPeriodForCashInSeptemberPricePerShare>
<bcli:StockIssuedDuringPeriodForCashInMarchPricePerShare contextRef="Context_6ME_31-Mar-2001" unitRef="USD_per_Share" decimals="4">0.0375</bcli:StockIssuedDuringPeriodForCashInMarchPricePerShare>
<bcli:PricePerShareOfStockIssuedDuringPeriodToPurchaseMineralOption contextRef="Context_FYE_31-Mar-2004" unitRef="USD_per_Share" decimals="3">0.065</bcli:PricePerShareOfStockIssuedDuringPeriodToPurchaseMineralOption>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005" unitRef="USD_per_Share" decimals="2">0.01</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJune>
<bcli:StockIssuedExpenses contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">25000000</bcli:StockIssuedExpenses>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Mar-2005" unitRef="USD_per_Share" decimals="2">0.75</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Dec-2007" unitRef="USD_per_Share" decimals="4">0.1818</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Dec-2008" unitRef="USD_per_Share" decimals="4">0.1818</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>

<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006" unitRef="USD_per_Share" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInMay>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006" unitRef="USD_per_Share" decimals="2">0.60</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJuly>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006" unitRef="USD_per_Share" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInSeptember>
<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006" unitRef="USD_per_Share" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInDecember>
<bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement contextRef="Context_FYE_31-Dec-2008" unitRef="USD_per_Share" decimals="4">0.1818</bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement>
<bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement contextRef="Context_FYE_31-Dec-2010" unitRef="USD_per_Share" decimals="2">0.12</bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement>
<us-gaap:OtherDepreciationAndAmortization contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">38000</us-gaap:OtherDepreciationAndAmortization>
<us-gaap:OtherDepreciationAndAmortization contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">33000</us-gaap:OtherDepreciationAndAmortization>
<us-gaap:OtherDepreciationAndAmortization contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_6">1191000</us-gaap:OtherDepreciationAndAmortization>
<us-gaap:SeveranceCosts contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">1000</us-gaap:SeveranceCosts>
<us-gaap:SeveranceCosts contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-2000</us-gaap:SeveranceCosts>
<us-gaap:SeveranceCosts contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_7">15000</us-gaap:SeveranceCosts>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_8">451000</us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_9">1864000</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_10">795000</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">449000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">4000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">195000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">128000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_11">21809000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
<us-gaap:StockOptionPlanExpense contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">1135000</us-gaap:StockOptionPlanExpense>
<us-gaap:StockOptionPlanExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">177000</us-gaap:StockOptionPlanExpense>
<us-gaap:StockOptionPlanExpense contextRef="Context_FYE_31-Dec-2012" unitRef="USD" decimals="-3">560000</us-gaap:StockOptionPlanExpense>
<us-gaap:StockOptionPlanExpense contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">203000</us-gaap:StockOptionPlanExpense>
<us-gaap:StockOptionPlanExpense contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_12">7584000</us-gaap:StockOptionPlanExpense>
<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">249000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-128000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_13">660000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">81000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-112000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_14">719000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">74000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">34000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_15">1321000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
<bcli:ErosionOfRestrictedCash contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:ErosionOfRestrictedCash>
<bcli:ErosionOfRestrictedCash contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</bcli:ErosionOfRestrictedCash>
<bcli:ErosionOfRestrictedCash contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_16">6000</bcli:ErosionOfRestrictedCash>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-746000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-670000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_17">-14933000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2004" unitRef="USD" decimals="-3">36000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_18">-23000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-746000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-670000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_19">-14956000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">52000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">20000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_20">1243000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInRestrictedCash>
<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInRestrictedCash>
<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_21">-6000</us-gaap:IncreaseDecreaseInRestrictedCash>
<us-gaap:PaymentsToAcquireShortTermInvestments contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-997000</us-gaap:PaymentsToAcquireShortTermInvestments>
<us-gaap:PaymentsToAcquireShortTermInvestments contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_22">1772000</us-gaap:PaymentsToAcquireShortTermInvestments>
<bcli:InvestmentInLeaseDeposit contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:InvestmentInLeaseDeposit>
<bcli:InvestmentInLeaseDeposit contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">-6000</bcli:InvestmentInLeaseDeposit>
<bcli:InvestmentInLeaseDeposit contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_23">-23000</bcli:InvestmentInLeaseDeposit>
<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-52000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">971000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_24">-3032000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2004" unitRef="USD" decimals="-3">16000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_25">-16000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-52000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">971000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_26">-3048000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">1418000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_30-Sep-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">225000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">308000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">135000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_31-Jan-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorOneMember" unitRef="USD" decimals="-3">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorTwoMember" unitRef="USD" decimals="-3">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorThreeMember" unitRef="USD" decimals="-3">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>

<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-5">4900000</us-gaap:ProceedsFromIssuanceOfCommonStock>

<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_27">17592000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_28">2061000</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_29">777000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:RepaymentsOfOtherShortTermDebt>
<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:RepaymentsOfOtherShortTermDebt>
<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_30">601000</us-gaap:RepaymentsOfOtherShortTermDebt>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">250000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_31">19829000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2004" unitRef="USD" decimals="-3">57000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_32">43000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">250000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_33">19872000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-778000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_31-Mar-2013" unitRef="USD" decimals="-3">551000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_157ME_31-Mar-2013" unitRef="USD" decimals="-3" id="Footnote-1_34">1868000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>

<bcli:GeneralAndGoingConcernDisclosureTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0in;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 0.75in;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;NOTE&amp;#160;1&amp;#160;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;GENERAL&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;A.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Brainstorm Cell Therapeutics Inc. (formerly: Golden Hand Resources Inc. - the "Company") was incorporated in the State of Washington on September 22, 2000.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;B.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On May 21, 2004, the former major stockholders of the Company entered into a purchase agreement with a group of private investors, who purchased from the former major stockholders 6,880,000 shares of the then issued and outstanding 10,238,000 shares of Common Stock.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;C.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On July 8, 2004, the Company entered into a licensing agreement with Ramot of Tel Aviv University Ltd. ("Ramot"), to acquire certain stem cell technology (see Note 4). Subsequent to this agreement, the Company decided to focus on the development of novel cell therapies for neurodegenerative diseases based on the acquired technology and research to be conducted and funded by the Company.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Following the licensing agreement dated July 8, 2004, the management of the Company decided to abandon all old activities related to the sale of the digital data recorder product. The discontinuation of this activity was accounted for under the provision of Statement of Financial Accounting Standard ASC 360-10, "Accounting for the Impairment or Disposal of Long-Lived Assets".&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 84.45pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;D.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On October 25, 2004, the Company formed a wholly-owned subsidiary in Israel, Brainstorm Cell Therapeutics Ltd. ("BCT").&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;E.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On November 18, 2004, the Company changed its name from Golden Hand Resources Inc. to Brainstorm Cell Therapeutics Inc. to better reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. BCT, as defined above, owns all operational property and equipment.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The Common Stock is registered and publicly traded on the OTC Markets Group service of the National Association of Securities Dealers, Inc. under the symbol BCLI.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;F.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On September 17, 2006, the Company changed the Company's fiscal year-end from March 31 to December 31. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;G.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In December 2006, the Company changed its state of incorporation from Washington to Delaware. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;H.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Since its inception, the Company has devoted substantially all of its efforts to research and development, recruiting management and technical staff, acquiring assets and raising capital. In addition, the Company has not generated revenues. Accordingly, the Company is considered to be in the development stage, as defined in Statement of Financial Accounting Standards No. 7, "Accounting and reporting by development Stage Enterprises" ASC 915-10.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;; font-family:times new roman,times" size="2"&gt;I.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;In October 2010, the Israeli Ministry of Health (&amp;#8220;MOH&amp;#8221;) granted clearance for a Phase I/II clinical trial using the Company&amp;#8217;s autologous NurOwn stem cell therapy in patients with &lt;/font&gt;&lt;font style="font-weight: normal;"&gt;amyotrophic lateral sclerosis&lt;/font&gt; (&amp;#8220;&lt;font style="font: 10pt times new roman, times, serif;"&gt;ALS&amp;#8221;), subject to some additional process specifications as well as completion of the sterility validation study for tests performed.&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On February 23, 2011, the Company submitted, to the MOH, all the required documents. Following approval of the MOH, a Phase I/II clinical study for ALS patients using the Company&amp;#8217;s autologous NurOwn stem cell therapy (the &amp;#8220;Clinical Trial&amp;#8221;) was initiated in June 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;J&lt;/b&gt;.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-style: normal; font-weight: normal;; font-family:times new roman,times" size="2"&gt;In February 2011, the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) granted orphan drug designation to the Company&amp;#8217;s NurOwn autologous adult stem cell product for the treatment of ALS.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On February 19, 2013, Brainstorm Ltd established a wholly-owned subsidiary, Brainstorm Cell&amp;#160;&amp;#160;&amp;#160; Therapeutics UK Ltd. (&amp;#8220;Brainstorm UK&amp;#8221;). Brainstorm UK will act on behalf of the parent Company in the EU.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On February 21, 2013, Brainstorm UK filed a request for Orphan Medicinal Product Designation by the European Medicine Agency (EMA) for its Autologous Bone Marrow derived Mesenchyme Stromal cells Secreting Neurotropic factors (MSC-NTF, NurOwn).&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin: 0px;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: left; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;GOING CONCERN:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: left; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;As reflected in the accompanying financial statements, the Company&amp;#8217;s operations for the three months ended March 31, 2013, resulted in a net loss of $1,082. The Company&amp;#8217;s balance sheet reflects an accumulated deficit of $48,590. These conditions, together with the fact that the Company is a development stage Company and has no revenues nor are revenues expected in the near future, raise substantial doubt about the Company's ability to continue to operate as a going concern. The Company&amp;#8217;s ability to continue operating as a &amp;#8220;going concern&amp;#8221; is dependent on several factors, among them is its ability to raise sufficient additional working capital.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In 2009, the Company decided to focus only on the effort to commence clinical trials for ALS and such trials did commence in 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In July 2012, the Company raised $4.9 million, net, in a public offering (See Note 6B (i)). However, there can be no assurance that additional funds will be available on terms acceptable to the Company, or at all.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern&lt;/font&gt;&lt;/p&gt;</bcli:GeneralAndGoingConcernDisclosureTextBlock>
<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 2&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2012 are applied consistently in these financial statements.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
<bcli:ResearchAndLicenseAgreementTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 4&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;RESEARCH AND LICENSE AGREEMENT&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;The Company has a Research and License Agreement, as amended and restated, with Ramot. The Company obtained a waiver and release from Ramot pursuant to which Ramot agreed to an amended payment schedule regarding the Company's payment obligations under the Research and License Agreement and waived all claims against the Company resulting from the Company's previous defaults and non-payment under the Research and License Agreement. The waiver and release amended and restated the original payment schedule under the original agreement providing for payments during the initial research period and additional payments for any extended research period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;As of December 24, 2009, the Company had paid to Ramot $400 but did not make payments totaling $240 for the initial research period and payments totaling $380 for the extended research period. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On December 24, 2009, the Company and Ramot entered into a settlement agreement which amended the Research and License Agreement, as amended and restated pursuant to which, among other things, the following matters were agreed upon:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;a)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Ramot released the Company from its obligation to fund the extended research period in the total amount of $1,140. Therefore, the Company reversed an amount in 2009, equal to $760, from it research and development expenses that were previously expensed.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;b)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Past due amounts of $240 for the initial research period plus interest of $32 owed by the Company to Ramot was converted into 1,120,000 shares of common stock on December 30, 2009. Ramot was required to deposit the shares with a broker and only sell the shares in the open market after 185 days from the issuance date.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;c)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In the event that the total proceeds generated by sales of the shares on December 31, 2010, together with the March 31, 2010 payment, were less than $240 on or prior to December 31, 2010, then on such date the Company would pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240. Related compensation in the amount of $51 was recorded as research and development expenses.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In January 2011, Ramot sold an additional 167,530 shares of Common Stock of the Company, for $35, which finalized the sale of the 1,120,000 Common Stock of the Company granted to Ramot for $235. In February 2011, the Company paid the remaining $5 and finalized the balance due to Ramot according to the settlement agreement between the parties dated December 24, 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;The Company is to pay Ramot royalties on Net Sales on a Licensed Product by Licensed Product and jurisdiction by jurisdiction basis as follow:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;a)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;So long as the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is covered by a Valid Claim or is covered by Orphan Drug Status in such jurisdiction &amp;#8211; 5% of all Net Sales.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;b)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In the event the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is not covered by a Valid Claim and not covered by Orphan Drug status in such jurisdiction &amp;#8211; 3% of all Net Sales until the expiration of 15 years from the date of the First Commercial Sale of such Licensed Product in such jurisdiction.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</bcli:ResearchAndLicenseAgreementTextBlock>
<bcli:ConsultingAgreementsTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0in;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 5&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;CONSULTING AGREEMENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;A.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On July 8, 2004, the Company entered into two consulting agreements with Prof. Eldad Melamed and Dr. Daniel Offen (together, the "Consultants"), under which the Consultants provide the Company scientific and medical consulting services in consideration for a monthly payment of $6 each. In addition, the Company granted each of the Consultants, a fully vested warrant to purchase 1,097,215 shares of Common Stock at an exercise price of $0.01 per share. The warrants issued pursuant to the agreement were issued to the Consultants effective as of November 4, 2004. Each of the warrants is exercisable for a seven-year period beginning on November 4, 2005. As of September 2010, all the above warrants had been exercised. In June 2012 an amendment was signed with Dr. Daniel Offen, according to which the company pays Daniel Offen a monthly payment of $6, out of which $3 in cash and $3 by grant of Company stock.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;B&lt;font style="font-weight: normal;"&gt;.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On December 16, 2010, the Company approved a grant of 1,100,000&lt;/font&gt; &lt;font style="font-weight: normal;"&gt;shares of the Company's Common Stock to the two Consultants, for services rendered through December 31, 2010. Related compensation in the amount of $220 was recorded as research and development expense. A sum of $487 was cancelled concurrently with the issuance of the 1,100,000 shares of Common Stock of the Company.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;C&lt;font style="font-weight: normal;"&gt;.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On June 27, 2011, the Company approved an additional grant of 400,000&lt;/font&gt; &lt;font style="font-weight: normal;"&gt;shares of the Company's Common Stock to Prof. Daniel Offen, for services rendered through December 31, 2009. Related compensation in the amount of $192 was recorded as research and development expense.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;D&lt;font style="font-weight: normal;"&gt;.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On August 1, 2012, the Company approved an additional grant of 623,077&lt;/font&gt; &lt;font style="font-weight: normal;"&gt;shares of the Company's Common Stock to the Consultants, for services rendered from January 1, 2011 through June 30, 2012. Related compensation in the amount of $162 was recorded as research and development expense.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;E.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On January 16, 2013, the Company granted the Consultants an aggregate of 216,000 shares of Common Stock for their services from January 1, 2012 through December 31, 2012. Related compensation in the amount of $54 was recorded as research and development expense.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</bcli:ConsultingAgreementsTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0in;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;NOTE 6&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;STOCK CAPITAL&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27.75pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;A.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;The rights of Common Stock are as follows:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 84.45pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Holders of Common Stock have the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company and the right to receive dividends, if declared.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The Common Stock is registered and publicly traded on the OTC Markets Group service of the National Association of Securities Dealers, Inc. under the symbol BCLI.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;B.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Issuance of shares, warrants and options:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Private placements and public offering:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;During 2004 and 2005 the Company issued, in separate transactions, 8,861,875 shares of Common Stock of the Company for total proceeds of $308&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(b)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font-weight: normal;"&gt;On February 23, 2005, the Company completed a private placement for sale of 1,894,808 units for total proceeds of $1,418. Each unit consisted of one share of Common Stock and a three-year warrant to purchase one share of Common Stock at $2.50 per share. This private placement was consummated in three tranches which closed in October 2004, November 2004 and February 2005.&lt;/font&gt; &lt;font style="font-weight: normal;"&gt;All warrants are no longer valid&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 170.1pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(c)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On August 11, 2005, the Company signed a private placement agreement with investors for the sale of up to 1,250,000 units at a price of $0.80 per unit. Each unit consisted of one share of Common Stock and one warrant to purchase one share of Common Stock at $1.00 per share. The warrants were exercisable for a period of three years from issuance. On September 30, 2005, the Company sold 312,500 units for total net proceeds of $225. On December 7, 2005, the Company sold 187,500 units for total net proceeds of $135. All warrants are no longer valid.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(d)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In July 2007, the Company entered into an investment agreement, that was amended in August 2009, according to which for an aggregate subscription price of up to $5 million, the Company issued 41,666,667 shares of Common Stock and a warrant to purchase 10,083,333 shares of the Company's common stock at an exercise price of $0.20 per share and a warrant to purchase 20,166,667 shares of common stock at an exercise price of $0.29 per share. The warrants may be exercised at any time and expire on November 5, 2013. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In January 2011, the Company and an investor signed an agreement to balance the remaining amount due to the investor, totaling $22, against the remaining balance of the investment and the Company issued the above shares and warrants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In addition, the Company issued an aggregate of 1,250,000 shares of Common Stock to a related party as an introduction fee for the investment. As of the balance sheet date, no warrants have been exercised.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: left; margin: 0pt 0px 0pt 170.1pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 30.6pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(e)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In January 2010, the Company issued 1,250,000 units to a private investor for total proceeds of $250. Each unit consisted of one share of Common Stock and a two-year warrant to purchase one share of Common Stock at $0.50 per share. All warrants are no longer valid.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -30.6pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 112.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 31.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;(f)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;In February 2010, the Company issued 6,000,000 shares of Common Stock to three investors (2,000,000 to each investor) and warrants to purchase an aggregate of 3,000,000 shares of Common Stock (1,000,000 to each investor) with an exercise price of $0.50 for aggregate proceeds of $1,500 ($500 each).&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -30.6pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 30.6pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;(g)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;In February 2011, the Company issued 833,333 shares of Common Stock, at a price of $0.30 per share, and a warrant to purchase 641,026 shares of the Company's Common Stock at an exercise price of $0.39 per share exercisable for one year for total proceeds of $250. The warrants are no longer valid.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -31.5pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 112.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 31.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;(h)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On February 23, 2011, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to 12,815,000 shares of Common Stock, for an aggregate subscription price of up to $3.6 million and warrants to purchase up to 19,222,500 shares of Common Stock as follows: warrant to purchase 12,815,000 shares of Common Stock at $0.5 per share for two years, and warrants to purchase 6,407,500 shares of Common Stock at $0.28 per share for one year, out of which 946,834 were exercised, and 5,460,666 were cancelled.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -31.5pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;In addition, the Company agreed to pay 10% of the funds received for the distribution services received, out of this amount, 4% was be paid in stock and the remaining 6% in cash. Accordingly, in March 2011, the Company issued 512,600 shares of Common Stock and paid $231.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 112.5pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 31.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;(I)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On July 17, 2012, the Company raised $5.7 million gross proceeds through a public offering (&amp;#8220;Public Offering&amp;#8221;) of its common stock. The Company issued a total of 19,818,968 common stock of $0.00005 par value, ($0.29 per share) and 14,864,228 warrants to purchase 0.75 shares of Common Stock for every share purchased in the Public Offering, at an exercise price of $0.29 per share. The Warrants are exercisable until the 30 month anniversary of the date of issuance. After deducting closing costs and fees, the Company received net proceeds of approximately $4.9&amp;#160;million.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;The Company paid to the Placement Agency, Maxim Group LLC (the &amp;#8220;Placement Agent&amp;#8221;) a cash fee equal to 6% of the gross proceeds of the Public Offering and a corporate finance fee of 1% of the gross proceeds of the Public Offering, as well as fees and expenses of the Placement Agent of $1,000.&amp;#160;&amp;#160;In addition, the Company issued to the Placement Agent a two year warrant to purchase up to 493,966 shares of Common Stock (equal to 3% of the number of shares sold in the Public Offering), with an exercise price equal to $0.348 (120% of the Public offering price). The Warrants are exercisable until the 30 month anniversary of the date of issuance. In addition, the Company issued to Leader Underwriters (1993) Ltd, warrants to purchase 232,758 shares of Common stock, at an exercise price of $0.29 per share. The warrants are exercisable until the 30 month anniversary of the date of issuance.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 30.6pt;"&gt;&lt;font style="font: bold 10pt times new roman, times, serif;; font-family:times new roman,times" size="2"&gt;(j)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font: 10pt times new roman, times, serif;; font-family:times new roman,times" size="2"&gt;On February 4, 2013, the Company issued 126,111 shares of Common Stock to an investor, according to a settlement agreement, for the correction of the conversion rate of a $200 convertible loan. The convertible loan was issued in 2006 and converted in 2010.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -30.6pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 30.6pt;"&gt;&lt;font style="font: bold 10pt times new roman, times, serif;; font-family:times new roman,times" size="2"&gt;(k)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;On February 7, 2013, the Company issued 833,334&lt;/font&gt; &lt;font style="font: 10pt times new roman, times, serif;"&gt;units to a private investor for total proceeds of $250. Each unit consisted of one share of Common Stock and a warrant to purchase one share of Common Stock at $0.50 per share exercisable for 32 months. &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -30.6pt; margin: 0pt 0px 0pt 2in; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Share-based compensation to employees and to directors:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Options to employees and directors:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On November 25, 2004, the Company's stockholders approved the 2004 Global Stock Option Plan and the Israeli Appendix thereto (which applies solely to participants who are residents of Israel) and on March 28, 2005, the Company's stockholders approved the 2005 U.S. Stock Option and Incentive Plan, and the reservation of 9,143,462 shares of Common Stock for issuance in the aggregate under these stock plans.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Each option granted under the plans is exercisable until the earlier of ten years from the date of grant of the option or the expiration dates of the respective option plans. The 2004 and 2005 options plans will expire on November 25, 2014 and March 28, 2015, respectively. The exercise price of the options granted under the plans may not be less than the nominal value of the shares into which such options are exercised. The options vest primarily over three years. Any options that are canceled or forfeited before expiration become available for future grants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In June 2008, June 2011 and in June 2012, the Company's stockholders approved increases in the number of shares of common stock available for issuance under these stock option plans by 5,000,000, 5,000,000 and 9,000,000 shares, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;From 2005 through 2009, the Company granted its directors options to purchase 800,000 (in total) shares of Common Stock of the Company at an exercise price of $0.15 per share. The options are fully vested and will expire after 10 years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On June 22, 2006, the Company entered into an amendment to the Company's option agreement with two of its employees. The amendment changed the exercise price of 270,000 options granted to them from $0.75 to $0.15 per share. The excess of the fair value resulting from the modification, in the amount of $2, was recorded as general and administration expense over the remaining vesting period of the options.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: left; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On October 23, 2007, the Company granted to its former Chief Executive Officer an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.87 per share. On November 5, 2008, the Company amended the exercise price to $0.15 per share. The option is fully vested and expires after 10 years. The total compensation related to the option is $737, which was recorded as general and administrative expense. The options were all exercised for $150.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On June 29, 2009, the Company granted to its former Chief Executive Officer and director an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.067 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. Out of which 483,333 were exercised for $32 and 516,667 were cancelled.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The total compensation related to the option is $68, which is amortized over the vesting period as general and administrative expense. In February 2011, the former CEO resigned. On July 25, 2011, the Company signed a settlement agreement with the former CEO under which 483,333 shares out of the above grant became fully vested and exercisable through April 30, 2012. An additional $30 was written as compensation in general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In April 2012, the former CEO exercised the option to 483,333 shares of Common Stock for an exercise price of $32.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;"&gt;On June 29, 2009, the Company granted to its former Chief Financial Officer an option to purchase 200,000 shares of Common Stock at an exercise price of $0.067 per share. The option vested with respect to 1/3 of the shares subject to the option. In connection with the former Chief Financial Officer&amp;#8217;s resignation,&lt;/font&gt;&lt;font style="font-weight: normal;"&gt; &lt;font style="font-family: times new roman, times, serif;"&gt;2/3 of the above shares were cancelled and the remaining 66,667 were exercised for $4.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On April 13, 2010, the Company, Abraham Israeli and Hadasit Medical Research Services and Development Ltd. (&amp;#8220;Hadasit&amp;#8221;) entered into an Agreement (the &amp;#8220;Agreement&amp;#8221;) pursuant to which Prof. Israeli agreed, during the term of the Agreement, to serve as (i) the Company&amp;#8217;s Clinical Trials Advisor and (ii) a member of the Company&amp;#8217;s Board of Directors.&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In consideration of the services to be provided by Prof. Israeli to the Company under the Agreement, the Company agreed to grant equity annually during the term of the Agreement for the purchase of its Common Stock, as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="width: 17.85pt;"&gt;&lt;font style="font-family: symbol; font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;; font-family:times new roman,times" size="2"&gt;An option for the purchase of 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share to Prof. Israeli; and&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="width: 17.85pt;"&gt;&lt;font style="font-family: symbol; font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;; font-family:times new roman,times" size="2"&gt;A warrant for the purchase of 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share to Hadasit,&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Such options and warrants will vest and become exercisable in twelve (12) consecutive equal monthly amounts.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Accordingly, the Company granted to Prof. Israeli in each of April 2010, June 2011 and April 2012, an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The aggregated compensation related to such warrants recorded as of December 31, 2012 is $126 was classified as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;In addition, the Company granted Hadasit, in each of April 2010, June 2011 and April 2012, a warrant to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. The aggregated compensation related to the options recorded as of December 31, 2012 is $24 was classified as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On December 16, 2010, the Company granted to two of its directors an option to purchase 400,000 shares of Common Stock at an exercise price of $0.15 per share. The options are fully vested and are exercisable for a period of 10 years. The compensation related to the option, in the amount of $78, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On December 16, 2010, the Company approved the grant to its three Scientific Board members 300,000 shares of Common Stock of the Company. The compensation related to the option, in the amount of $60, was recorded as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In January 2011, the Company granted to its former CEO, an option to purchase 450,000 shares of Common Stock of the Company at $0.20 per share. The total compensation related to the option is $177, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On June 27, 2011, the Company granted to three of its directors options to purchase an aggregate of 634,999 shares of Common Stock of the Company at $0.15 per share. The total compensation related to the option was $287, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On August 10, 2011, the Company granted to its CEO, an option to purchase 70,000 shares of Common Stock of the Company at $0.20 per share. The total compensation related to the option was $26, which was amortized as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On August 1, 2012, the Company granted to three of its directors options to purchase an aggregate of 460,000 shares of Common Stock of the Company at $0.15 per share. The total compensation related to the option was $105, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On August 1, 2012, the Company granted to its former CEO, an option to purchase 70,000 shares of Common Stock of the Company at $0.26 per share. The total compensation expense related to the option was $16, which was amortized as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On January 24, 2013, the Company granted its new Chief Executive Officer an option to purchase 4,000,000 shares of Common Stock at an exercise price of $0.29 per share. The option will vest 33% of the shares subject thereto on the first anniversary of the date of grant and the remainder shall vest over 36 consecutive months.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The Company also agreed in the Employment Agreement dated January 24, 2013 to grant its Chief Executive Officer an additional option to purchase 2,000,000 shares of Common Stock, if certain conditions precedent occur prior to January 24 2014. Such option, which has not been granted at this time, would have an exercise price of $0.29 per share and vest as to 33.33% of the number of shares after one year, and the remainder of the shares would become exercisable in 36 consecutive, equal monthly installments thereafter.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;A summary of the Company's option activity related to options to employees and directors, and related information is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 70%; border-collapse: collapse; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;For&amp;#160;the&amp;#160;three&amp;#160;months&amp;#160;ended&amp;#160;&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&amp;#160;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Amount&amp;#160;of&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;options&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Weighted&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;average&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;exercise&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;price&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Aggregate&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;intrinsic&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;value&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 61%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,751,665&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Cancelled&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;8,751,665&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;175,033&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Vested and expected-to-vest at end of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,187,360&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;293,115&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the fair market value of the Company&amp;#8217;s shares on March 31, 2013 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2013.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(b)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Restricted shares to directors:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;From May 2006 through April 2007, the Company issued to its directors 400,000 restricted shares of Common Stock (100,000 each). The restrictions on the shares have fully lapsed. The compensation related to the stocks issued amounted to $198, which was amortized over the vesting period as general and administrative expenses. On August 27, 2008, the Company issued to its director 960,000 shares of Common Stock upon a cashless exercise by a shareholder of a warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $.01 per share that was acquired by the shareholder from Ramot. The shares were allocated to the director by the shareholder.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In May and June 2010, based on a board resolution dated June 29, 2009, the Company issued to three directors, three of its Scientific Advisory Board members and two of its Advisory Board members 800,000 restricted shares of Common Stock. The shares will vest in three annual and equal portions commencing with the grant date.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On December 16, 2010, the Company approved a grant to two of its directors 400,000 (total) shares of Common Stock. Related compensation in the amount of $80 was recorded as general and administrative costs in 2010. These shares were actually granted in June 2011, and an additional related compensation in the amount of $112 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On June 27, 2011, the Company granted to two of its directors 476,666 (total) shares of Common Stock, which shares are fully vested as of March 31, 2013. Related compensation in the amount of $229 will be recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;On August 22, 2011, the Company entered into an agreement with Chen Schor (the &amp;#8220;Executive Director Agreement&amp;#8221;) pursuant to which the Company granted to Mr. Schor 923,374 shares of restricted Common Stock of the Company.&amp;#160;&amp;#160; The shares will vest over 3 years - 1/3 upon each anniversary of the Grant Date.&lt;/font&gt; &lt;font style="font: 10pt times new roman, times, serif;"&gt;In addition, the Company will pay $15 per quarter to Mr. Schor for his services as an Executive Board Member. &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In August 2011, the Company issued to three of its Scientific Advisory Board members and three of its Advisory Board members a total of 300,000 restricted shares of Common Stock. The shares will vest in equal monthly portions over the service period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In November 2011, the Company issued to four of its Advisory Board members a total of 500,000 restricted shares of Common Stock. The shares will vest in equal monthly portions over the service period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In addition, in November 2011, the Company issued to a former director 250,000 shares of Common Stock. Related compensation in the amount of $70 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;In August 2012, the Company issued to two directors, four of its Scientific Advisory Board members and three of its Advisory Board members a total of 885,000 restricted shares of Common Stock. The shares will vest in 12 equal monthly portions over the service period. Related compensation in the amount of $198 will be recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Shares and warrants to investors and service providers:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font-size: 10pt; font-weight: normal;"&gt;The Company accounts for shares and warrant grants issued to non-employees using the guidance of&lt;/font&gt; &lt;font style="font-size: 10pt; font-weight: normal;"&gt;ASC 505-50, "Equity-Based Payments to Non-Employees" (EITTF 96-18, "Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling, Goods or Services"), whereby the fair value of such option and warrant grants is determined using a Black-Scholes options pricing model at the earlier of the date at which the non-employee's performance is completed or a performance commitment is reached.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 163.2pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 134.85pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;a)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;Warrants to investors and service providers and investors: &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: center; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 100%; border-collapse: collapse; font: 7pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Issuance&amp;#160;date&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Number&amp;#160;of&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;warrants&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;issued&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercise&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Price&amp;#160;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Warrants&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;exercisable&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercisable&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;through&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 16%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;November-December 2004&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,600,845&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,396,010&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;204,835&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.00005 - 0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 17%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February-December 2005&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,058,471&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;173,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2,548,308&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;337,163&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 2.5 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;337,163&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jun - Dec 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February-December 2006&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,686,355&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;727,696&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;478,659&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;480,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.005 &amp;#8211; 1.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;480,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb - May 2016&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March 2007&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,803,300&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,003,300&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13,800,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 0.47&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13,800,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Oct 2017&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2008&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Sep 2018&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr-Oct 2009&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,937,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;100,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,837,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.067 &amp;#8211; 0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,837,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Oct 2019&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;January 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,250,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,250,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;125,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;125,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2020&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.00005&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2020&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;January 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;641,026&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;641,026&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;6,407,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;946,834&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;5,460,666&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.28&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2013&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2021&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;30,556&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2022&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.348&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jul 2014&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jan 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jan 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Oct 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;95,061,785&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;16,468,540&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,586,794&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;64,006,451&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;63,003,673&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: left; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.5pt; margin: 0pt 0px 0pt 163.2pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 134.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;Warrants to investors and service providers and investors: &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The fair value for the warrants to service providers was estimated on the measurement date determined using a Black-Scholes option pricing model, with the following weighted-average assumptions for the year ended December 31, 2010; weighted average volatility of 140%, risk free interest rates of 2.39%-3.14%, dividend yields of 0% and a weighted average life of the options of 5-5.5 and 1-9 years. There were no grants to service providers during 2012 and 2013 using Black-Scholes calculation. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;(b)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Shares:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On June 1 and June 4, 2004, the Company issued 40,000 and 150,000 shares of Common Stock for 12 months of filing services and legal and due-diligence services, respectively, with respect to a private placement. Compensation expense related to filing services, totaling $26, was amortized over a 12-month period. Compensation related to legal services, totaling $105 was recorded as equity issuance cost and had no effect on the statement of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On February 10, 2005, the Company signed an agreement with one of its service providers under which the Company issued to the service provider 100,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;In March and in April 2005, the Company signed an agreement with four members of its Scientific Advisory Board under which the Company issued to the members of the Scientific Advisory Board 400,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan (100,000 each). All restrictions on these shares have lapsed&lt;/font&gt;&lt;font style="font-weight: normal;"&gt;. &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;Between the years 2004 through 2009, the Company issued to several services providers, in separate transactions, 3,045,508 shares of Common Stock in total. The total related compensation, in the amount of $758, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On March 5, 2007, the Company issued a $150 Convertible Promissory Note to a third party. Interest on the note accrued at the rate of 8% per annum for the first year and 10% per annum after the first year. On January 27, 2010, the third party converted the entire accrued principle and interest outstanding under the note, amounting to $189, into 1,016,109 shares of Common Stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On October 29, 2007, the Company issued to a Scientific Advisory Board member 80,000 shares of the Company&amp;#8217;s Common Stock for scientific services. Compensation of $67 was recorded as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On May 20, 2008, the Company issued to its finance advisor 90,000 shares of the Company's common stock. The shares are for $35 payable to the finance advisor for introduction fee of past convertible loans. Related compensation in the amount of $36 is recorded as finance expenses.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On April 5, 2009, the Company issued to its Chief Technology Advisor 1,800,000 shares of Common Stock. The shares are for $180 payable to the advisor. Related compensation in the amount of $144 was recorded as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On October 1, 2009, the Company issued to its service provider 150,000 shares of the Company's Common Stock. The shares are for financial and investor relation services done by the provider. Related compensation in the amount of $51 is recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On October 2, 2009, the Company issued to its service provider 1,250,000 shares of the Company's Common Stock. The shares are for investor and public relation services. Related compensation in the amount of $400 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On December 30, 2009, the Company issued to Ramot 1,120,000 shares of the Company's Common Stock (See Note 4).&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On December 13, 2009, the Company issued a $135 Convertible Promissory Note to it legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the note accrued at the rate of 4%.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On January 5, 2010, the Company issued to its public relations advisor 50,000 shares of the Company's Common Stock for six months service. The issuance of the shares is part of the agreement with the public relations advisor that entitles it to a monthly grant of 8,333 shares of the Company's Common Stock. Related compensation in the amount of $12 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On January 6, 2010, the Company issued to its service provider 60,000 shares of the Company's Common Stock. The shares are for $15 payable to the service provider for insurance and risk management consulting and agency services for three years. Related compensation in the amount of $16 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On February 19, 2010, the Company's legal advisor converted the entire accrued principal and interest amount outstanding under the note into 402,385 shares of Common Stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 143pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On April 6, 2010, Prof. Melamed fully exercised his warrant to purchase 1,097,215 shares of the Company&amp;#8217;s Common Stock. The warrant was issued to him pursuant to the agreement with the Consultants effective as of November 4, 2004 (See Note 5a).&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;In May 2010, based on a board resolution dated June 29, 2009, the Company issued to one of its public relations advisors 100,000 restricted shares of Common Stock. The shares will vest in three annual and equal portions commencing with the grant date. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On December 16, 2010, the Company granted to its service provider 200,000 shares of the Company's Common Stock. The shares are for investor and public relations services. Related compensation in the amount of $40 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;On December 16, 2010, the Company granted to its two consultants 1,100,000 shares of the Company's Common Stock (See Note 5B).&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On February 18, 2011, the Company's legal advisor converted the entire accrued principal and interest of the Convertible Promissory Note granted on September 15, 2010, totaling $137, into 445,617 shares of Common Stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On June 27, 2011, the Company granted to its legal advisor 180,000 shares of Common Stock for 2011 legal services. Related compensation in the amount of $86 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On June 27, 2011, the Company granted to its consultant 400,000 shares of the Company's Common Stock, for services rendered through December 31, 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 170.1pt; font: bold 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Related compensation in the amount of $192 was recorded as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On June 27, 2011, the Company granted to a service provider 10,870 shares of the Company's Common Stock. Related compensation in the amount of $5 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On December 31, 2011, the Company issued to Hadasit warrants to purchase up to 1,500,000 restricted shares of the Company's Common Stock at an exercise price of $0.001 per share, exercisable for a period of 5 years.&amp;#160;&amp;#160;The warrants shall vest over the course of the trials as follows: 500,000 upon enrollment of 1/3 of the patients; an additional 500,000 upon enrollment of all the patients and the final 500,000 upon completion of the study.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On January 16, 2013, the Company granted an aggregate of 216,000 shares of Common Stock of the Company to two consultants, for services rendered through December 31, 2012. Related compensation expense in the amount of $54 was recorded as research and development expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On March 11, 2013, the Company granted to its legal advisor 193,696 shares of Common Stock for 2013 legal services. As of March 31, 2013, related compensation expense in the amount of $11 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;On March 11, 2013, the Company granted to two of its service provider 400,000 an aggregate of shares of the Company's Common Stock. The shares are public relations services. As of March 31, 2013, related compensation expense in the amount of $31 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The total stock-based compensation expense, related to shares, options and warrants granted to employees, directors and service providers, was comprised, at each period, as follows: &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 70%; border-collapse: collapse; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Three&amp;#160;months&amp;#160;ended&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Period&amp;#160;from&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;September&amp;#160;22,&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2000&amp;#160;(inception&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;date)&amp;#160;through&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2012&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;U.S. $ in thousands&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 61%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Research and development&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;75&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;17,841&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;General and administrative&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;226&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;168&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;10,884&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Financial expenses, net&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;248&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;301&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;181&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;28,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0in;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 7&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;SUBSEQUENT EVENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;On April 8, 2013, the Company entered into an agreement with Dana-Farber Cancer Institute (&amp;#8220;Dana-Farber&amp;#8221;) to provide cGMP-compliant clean room facilities for production of the Company&amp;#8217;s NurOwn&amp;#8482; stem cell candidate during its upcoming Phase II ALS trial in the United States. The Company&amp;#8217;s Phase II trial, to be launched in the second half of 2013 pending FDA approval, will be conducted at Massachusetts General Hospital (&amp;#8220;MGH&amp;#8221;), the University of Massachusetts (&amp;#8220;UMass&amp;#8221;) Hospital and the Mayo Clinic. The Connell and O'Reilly Cell Manipulation Core Facility at Dana-Farber will produce NurOwn for the MGH and UMass Hospital clinical sites.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;On April 13, 2013, the Company granted Hadasit an option to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. The aggregated compensation expense related to the options will be recorded and classified as research and development expense.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;In addition, on April 13, 2013 the Company granted to Prof. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The aggregated compensation expense related to the options will be recorded and classified as general and administrative expense.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;On April 19, 2013, the Company issued to two of its directors and four of its Advisory Board members a total of 760,000 restricted shares of Common Stock. The shares will vest in 12 equal monthly portions until fully vested on the anniversary of grant. Related compensation expense in the amount of $175 will be recorded as general and administrative expense.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;E.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On April 19, 2013, the Company granted to three of its directors options to purchase an aggregate of 460,000 shares of Common Stock of the Company at $0.15 per share. The total compensation expense related to the option will be recorded as general and administrative expense.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 18pt;"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;On April 18, 2013, the &lt;font style="color: black;"&gt;stockholders of the Company authorized the Board of Directors of the Company, in its discretion, should it deem it to be appropriate and in the best interests of the Company and its stockholders, to amend the Company&amp;#8217;s Certificate of Incorporation to effect a reverse stock split of the Company&amp;#8217;s issued and outstanding shares of common stock by a ratio of between 1-for-10 and 1-for-20, inclusive, without further approval or authorization of the Company&amp;#8217;s stockholders.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;A summary of the Company's option activity related to options to employees and directors, and related information is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 72%; border-collapse: collapse; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;For&amp;#160;the&amp;#160;three&amp;#160;months&amp;#160;ended&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&amp;#160;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Amount&amp;#160;of&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;options&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Weighted&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;average&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;exercise&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;price&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Aggregate&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;intrinsic&lt;/font&gt;&lt;br /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;value&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 61%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,751,665&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width:
 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Cancelled&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;8,751,665&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align:
 left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;175,033&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Vested and expected-to-vest at end of period&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,187,360&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;293,115&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<bcli:ScheduleOfWarrantsIssuedToInvestorsServiceProvidersTableTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="text-align: justify;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;Warrants to investors and service providers and investors: &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: center; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 100%; border-collapse: collapse; font: 7pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Issuance&amp;#160;date&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Number&amp;#160;of&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;warrants&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;issued&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercise&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Price&amp;#160;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Warrants&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;exercisable&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Exercisable&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;through&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" colspan="2"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 16%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;November-December2004&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,600,845&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,396,010&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;204,835&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.00005 - 0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 17%;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February-December2005&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,058,471&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;173,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2,548,308&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;337,163&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 2.5 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;337,163&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jun - Dec 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February-December2006&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,686,355&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;727,696&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;478,659&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;480,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.005 &amp;#8211; 1.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;480,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb - May 2016&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March 2007&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,803,300&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,003,300&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13,800,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 0.47&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13,800,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Oct 2017&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2008&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.15 - 0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;9,175,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Sep 2018&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr-Oct2009&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,937,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;100,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,837,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 7pt;; font-family:times new roman,times" size="2"&gt;0.067 &amp;#8211; 0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,837,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013 &amp;#8211; Oct 2019&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;January 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,250,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,250,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;125,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;125,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;500,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2020&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2010&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.00005&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2020&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;January 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;4,537,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Nov 2013&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;641,026&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;641,026&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;6,407,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;946,834&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;5,460,666&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.28&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;February 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;12,815,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2013&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2011&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2021&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;April 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.01&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;30,556&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Apr 2022&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.348&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;493,966&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jul 2014&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;232,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jan 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;July 2012&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,864,228&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Jan 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Feb 2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;833,334&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Oct 2015&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;95,061,785&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;16,468,540&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;14,586,794&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;64,006,451&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;63,003,673&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: left; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
</bcli:ScheduleOfWarrantsIssuedToInvestorsServiceProvidersTableTextBlock>
<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;The total stock-based compensation expense, related to shares, options and warrants granted to employees, directors and service providers, was comprised, at each period, as follows: &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 70%; border-collapse: collapse; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Three&amp;#160;months&amp;#160;ended&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Period&amp;#160;from&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;September&amp;#160;22,&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2000&amp;#160;(inception&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;date)&amp;#160;through&lt;/font&gt;&lt;br  /&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;March&amp;#160;31,&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2012&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;U.S. $ in thousands&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 61%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Research and development&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;75&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 10%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;17,841&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;General and administrative&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;226&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;168&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;10,884&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Financial expenses, net&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;248&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;301&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;181&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;28,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&lt;font size="2" style="font-family:times new roman,times"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
<bcli:CommonStockTransferredAsPerPurchaseAgreement contextRef="Context_As_Of_21-May-2004" unitRef="shares" decimals="0">6880000</bcli:CommonStockTransferredAsPerPurchaseAgreement>
<bcli:ResearchLicenseAgreementExpensesPaid contextRef="Context_0ME_24-Dec-2009" unitRef="USD" decimals="-3">400000</bcli:ResearchLicenseAgreementExpensesPaid>

<bcli:ResearchLicensePaymentsMadeAsPerSettlementAgreement contextRef="Context_Custom_28-Feb-2011" unitRef="USD" decimals="-3">5000</bcli:ResearchLicensePaymentsMadeAsPerSettlementAgreement>
<bcli:SharesGrantedAsPerResearchAndLicenseAgreement contextRef="Context_FYE_31-Dec-2009" unitRef="shares" decimals="0">1120000</bcli:SharesGrantedAsPerResearchAndLicenseAgreement>
<bcli:NumberOfDaysOfRestrictionToSellSharesInOpenMarket contextRef="Context_FYE_31-Dec-2009">185 days</bcli:NumberOfDaysOfRestrictionToSellSharesInOpenMarket>

<bcli:NumberOfSharesSoldByPurchaserAsPermittedBySettlementAgreement contextRef="Context_Custom_31-Jan-2011" unitRef="shares" decimals="0">167530</bcli:NumberOfSharesSoldByPurchaserAsPermittedBySettlementAgreement>
<bcli:ProceedsFromSaleOfSharesAreLessThan240Conditions contextRef="Context_FYE_31-Dec-2009">Company would pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240.</bcli:ProceedsFromSaleOfSharesAreLessThan240Conditions>
<bcli:ProceedsFromSharesSoldByPurchaserAsPermittedBySettlementAgreement contextRef="Context_Custom_31-Jan-2011" unitRef="USD" decimals="-3">35000</bcli:ProceedsFromSharesSoldByPurchaserAsPermittedBySettlementAgreement>
<bcli:TotalValueOfSharesSoldByPurchaser contextRef="Context_Custom_31-Jan-2011" unitRef="USD" decimals="-3">235000</bcli:TotalValueOfSharesSoldByPurchaser>
<bcli:ObligationAmountToFundExtendedResearchPeriod contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="-3">1140000</bcli:ObligationAmountToFundExtendedResearchPeriod>
<bcli:ResearchAndDevelopmentExpensesReversed contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">760000</bcli:ResearchAndDevelopmentExpensesReversed>
<bcli:StockBasedCompensationRelatedToSharesGrantedUnderResearchLicenseAgreement contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">51000</bcli:StockBasedCompensationRelatedToSharesGrantedUnderResearchLicenseAgreement>
<bcli:ResearchLicenseInterestRate contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">32000</bcli:ResearchLicenseInterestRate>
<bcli:ResearchLicenseLiability contextRef="Context_As_Of_24-Dec-2009_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InitialResearchPeriodMember" unitRef="USD" decimals="-3">240000</bcli:ResearchLicenseLiability>
<bcli:ResearchLicenseLiability contextRef="Context_As_Of_24-Dec-2009_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ExtendedResearchPeriodMember" unitRef="USD" decimals="-3">380000</bcli:ResearchLicenseLiability>
<bcli:ConsultingAgreementDate contextRef="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember">2004-07-08</bcli:ConsultingAgreementDate>
<bcli:MonthlyPaymentOfConsultingFees contextRef="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="USD" decimals="-3">6000</bcli:MonthlyPaymentOfConsultingFees>
<bcli:MonthlyPaymentOfConsultingFees contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember" unitRef="USD" decimals="-3">6000</bcli:MonthlyPaymentOfConsultingFees>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="shares" decimals="0">1097215</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">10083333</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">20166667</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">3000000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorOneMember" unitRef="shares" decimals="0">1000000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorTwoMember" unitRef="shares" decimals="0">1000000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_InvestorThreeMember" unitRef="shares" decimals="0">1000000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">641026</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">19222500</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">12815000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">6407500</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_FYE_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">1500000</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_17-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_LeaderUnderwriters1993LtdMember" unitRef="shares" decimals="0">232758</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">14864228</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:CommonStockExercisePrice contextRef="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="USD_per_Share" decimals="2">0.01</bcli:CommonStockExercisePrice>
<bcli:WarrantsExercisableTerm contextRef="Context_FYE_31-Dec-2004_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember">P7Y</bcli:WarrantsExercisableTerm>
<bcli:SharesApprovedForServices contextRef="Context_As_Of_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="shares" decimals="0">1100000</bcli:SharesApprovedForServices>
<bcli:ConsultantChargesCancelled contextRef="Context_FYE_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="USD" decimals="-3">487000</bcli:ConsultantChargesCancelled>

<bcli:AdditionalSharesApprovedForServices contextRef="Context_As_Of_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember" unitRef="shares" decimals="0">623077</bcli:AdditionalSharesApprovedForServices>

<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Oct-2007_ProductOrServiceAxis_ScientificAdvisoryBoardMember" unitRef="shares" decimals="0">80000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_20-May-2008_ProductOrServiceAxis_FinancialAdvisorMember" unitRef="shares" decimals="0">90000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_30-Apr-2009_ProductOrServiceAxis_ChiefTechnologyAdvisorMember" unitRef="shares" decimals="0">1800000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderOneMember" unitRef="shares" decimals="0">1250000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">150000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Dec-2009_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">3045508</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">60000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_PublicRelationsAdvisorMember" unitRef="shares" decimals="0">50000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Dec-2010_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">200000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_31-Dec-2010_ProductOrServiceAxis_ConsultantsMember" unitRef="shares" decimals="0">1100000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">10870</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_LegalAdvisorMember" unitRef="shares" decimals="0">180000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ConsultantsMember" unitRef="shares" decimals="0">400000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

<bcli:MonthlyPaymentOfConsultingFeesCash contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember" unitRef="USD" decimals="-3">3000</bcli:MonthlyPaymentOfConsultingFeesCash>
<bcli:MonthlyPaymentOfConsultingFeesStock contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember" unitRef="USD" decimals="-3">3000</bcli:MonthlyPaymentOfConsultingFeesStock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31-Dec-2012" unitRef="shares" decimals="0">4751665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">8751665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_Custom_31-Dec-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="0">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="0">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="shares" decimals="0">14600845</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="shares" decimals="0">3058471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="shares" decimals="0">1686355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="shares" decimals="0">14803300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member" unitRef="shares" decimals="0">9175000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="shares" decimals="0">4937500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member" unitRef="shares" decimals="0">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member" unitRef="shares" decimals="0">125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember" unitRef="shares" decimals="0">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember" unitRef="shares" decimals="0">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member" unitRef="shares" decimals="0">4537500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member" unitRef="shares" decimals="0">641026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="shares" decimals="0">6407500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember" unitRef="shares" decimals="0">12815000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member" unitRef="shares" decimals="0">493966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember" unitRef="shares" decimals="0">232758</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember" unitRef="shares" decimals="0">14864228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member" unitRef="shares" decimals="0">833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">516667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="shares" decimals="0">5460666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="shares" decimals="0">204835</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="shares" decimals="0">2548308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="shares" decimals="0">478659</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="shares" decimals="0">1003300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member" unitRef="shares" decimals="0">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember" unitRef="shares" decimals="0">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member" unitRef="shares" decimals="0">641026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="shares" decimals="0">5460666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">4187360</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31-Dec-2012" unitRef="USD_per_Share" decimals="2">0.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31-Mar-2013" unitRef="USD_per_Share" decimals="2">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_3ME_31-Mar-2013" unitRef="USD_per_Share" decimals="2">0.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="Context_3ME_31-Mar-2013" unitRef="USD_per_Share" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="Context_3ME_31-Mar-2013" unitRef="USD_per_Share" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31-Mar-2013" unitRef="USD_per_Share" decimals="2">0.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">175033000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="Context_As_Of_31-Mar-2013" unitRef="USD" decimals="-3">293115000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="shares" decimals="0">337163</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="shares" decimals="0">480000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="shares" decimals="0">13800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member" unitRef="shares" decimals="0">9175000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="shares" decimals="0">4837500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember" unitRef="shares" decimals="0">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member" unitRef="shares" decimals="0">4537500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember" unitRef="shares" decimals="0">12815000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member" unitRef="shares" decimals="0">30556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member" unitRef="shares" decimals="0">493966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember" unitRef="shares" decimals="0">232758</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember" unitRef="shares" decimals="0">14864228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member" unitRef="shares" decimals="0">833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>

<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="shares" decimals="0">337163</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="shares" decimals="0">480000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="shares" decimals="0">13800000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member" unitRef="shares" decimals="0">9175000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="shares" decimals="0">4837500</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember" unitRef="shares" decimals="0">1500000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member" unitRef="shares" decimals="0">33334</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member" unitRef="shares" decimals="0">4537500</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember" unitRef="shares" decimals="0">12815000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member" unitRef="shares" decimals="0">33334</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member" unitRef="shares" decimals="0">33334</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member" unitRef="shares" decimals="0">493966</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember" unitRef="shares" decimals="0">232758</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember" unitRef="shares" decimals="0">14864228</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member" unitRef="shares" decimals="0">833334</us-gaap:ClassOfWarrantOrRightOutstanding>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="1">2.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Aug-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="0">1</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember" unitRef="USD_per_Share" decimals="2">0.20</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Aug-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Jan-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="2">0.39</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember" unitRef="USD_per_Share" decimals="2">0.28</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_AwardTypeAxis_RestrictedStockMember" unitRef="USD_per_Share" decimals="3">0.001</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_17-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_LeaderUnderwriters1993LtdMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="USD_per_Share" decimals="3">0.348</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>

<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="2">0.50</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member" unitRef="USD_per_Share" decimals="2">0.39</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember" unitRef="USD_per_Share" decimals="2">0.28</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member" unitRef="USD_per_Share" decimals="3">0.348</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member" unitRef="USD_per_Share" decimals="1">0.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="USD_per_Share" decimals="3">0.005</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MinimumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="USD_per_Share" decimals="3">0.067</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member" unitRef="USD_per_Share" decimals="1">2.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member" unitRef="USD_per_Share" decimals="1">1.5</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member" unitRef="USD_per_Share" decimals="2">0.47</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_3ME_31-Mar-2013_RangeAxis_MaximumMember_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentWarrantsExercisePrice>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateNovDec2004Member">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2005Member">Jun - Dec 2015</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFebDec2006Member">Feb - May 2016</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateMar2007Member">Nov 2013   Oct 2017</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2008Member">Nov 2013   Sep 2018</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateAprOct2009Member">Nov 2013   Oct 2019</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2010Member">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010Member">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010OneMember">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2010TwoMember">Feb-20</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2010Member">Apr-20</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJan2011Member">Nov-13</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011Member">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011OneMember">-</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2011TwoMember">Feb-13</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApr2011Member">Apr-21</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateApril2012Member">Apr-22</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012Member">Jul-14</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012OneMember">Jan-15</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateJuly2012TwoMember">Jan-15</bcli:WarrantExercisableTerm>
<bcli:WarrantExercisableTerm contextRef="Context_3ME_31-Mar-2013_MajorTypesOfDebtAndEquitySecuritiesAxis_IssuanceDateFeb2013Member">Oct-15</bcli:WarrantExercisableTerm>
<bcli:NumberOfWarrantsIssuedTotal contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">95061785</bcli:NumberOfWarrantsIssuedTotal>
<bcli:WarrantExercisedTotal contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">16468540</bcli:WarrantExercisedTotal>
<bcli:WarrantForfeitedTotal contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">14586794</bcli:WarrantForfeitedTotal>
<bcli:WarrantsOutstandingTotal contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">64006451</bcli:WarrantsOutstandingTotal>
<bcli:WarrantsExercisableTotal contextRef="Context_As_Of_31-Mar-2013" unitRef="shares" decimals="0">63003673</bcli:WarrantsExercisableTotal>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">168000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">13000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember" unitRef="USD" decimals="-3">181000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2012_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">226000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">75000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember" unitRef="USD" decimals="-3">301000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">10884000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">17841000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_TotalStockBasedCompensationMember" unitRef="USD" decimals="-3">28973000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_157ME_31-Mar-2013_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_InterestExpensesMember" unitRef="USD" decimals="-3">248000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="Context_FYE_31-Dec-2008_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member" unitRef="shares" decimals="0">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="Context_FYE_31-Dec-2011_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member" unitRef="shares" decimals="0">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="Context_FYE_31-Dec-2012_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member" unitRef="shares" decimals="0">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
<bcli:SharesReservedForIssuanceUnderStockOptionPlan contextRef="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004AndUSStockOptionAndIncentivePlan2005Member" unitRef="shares" decimals="0">9143462</bcli:SharesReservedForIssuanceUnderStockOptionPlan>
<bcli:UnitSoldComprisedOfOneShareAndOneWarrant contextRef="Context_Custom_31-Jan-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">1250000</bcli:UnitSoldComprisedOfOneShareAndOneWarrant>
<bcli:UnitSoldComprisedOfOneShareAndOneWarrant contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">833334</bcli:UnitSoldComprisedOfOneShareAndOneWarrant>


<bcli:UnitsSold contextRef="Context_Custom_30-Sep-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">312500</bcli:UnitsSold>
<bcli:UnitsSold contextRef="Context_Custom_31-Dec-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">187500</bcli:UnitsSold>
<bcli:StockBasedCompensationToLegalAdvisor contextRef="Context_Custom_30-Jun-2004_ProductOrServiceAxis_FilingServiceMember" unitRef="USD" decimals="0">105000</bcli:StockBasedCompensationToLegalAdvisor>
<bcli:PricePerUnit contextRef="Context_Custom_31-Aug-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="1">0.8</bcli:PricePerUnit>
<us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm contextRef="Context_Custom_31-Aug-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">3 Years</us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm>
<us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember">32 months</us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2006_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember" unitRef="USD" decimals="-3">2000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_FYE_30-Apr-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="USD" decimals="-3">198000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">737000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">68000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderOneMember" unitRef="USD" decimals="-3">400000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Oct-2009_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">51000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Dec-2009_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">758000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">16000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_PublicRelationsAdvisorMember" unitRef="USD" decimals="-3">12000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember" unitRef="USD" decimals="-3">80000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Dec-2010_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">40000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="-3">78000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Jan-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">177000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="USD" decimals="-3">229000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember" unitRef="USD" decimals="-3">112000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">5000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="-3">287000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_LegalAdvisorMember" unitRef="USD" decimals="-3">86000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>

<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Jul-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">30000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">26000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>

<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerDirectorMember" unitRef="USD" decimals="-3">70000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>

<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_30-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="-3">105000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ManagementMember" unitRef="USD" decimals="-3">198000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="-3">16000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="USD" decimals="-3">126000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_1ME_31-Mar-2013_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">31000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_1ME_31-Mar-2013_ProductOrServiceAxis_LegalAdvisorMember" unitRef="USD" decimals="-3">11000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses contextRef="Context_3ME_31-Mar-2013_SubsequentEventTypeAxis_SubsequentEventMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorsAndAdvisoryBoardMember" unitRef="USD" decimals="-3">175000</bcli:StockBasedCompensationRecordedInGeneralAndAdministrativeExpenses>
<bcli:CommonStockPurchasePrice contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD_per_Share" decimals="1">0.3</bcli:CommonStockPurchasePrice>
<bcli:CommonStockPurchasePrice contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD_per_Share" decimals="2">0.29</bcli:CommonStockPurchasePrice>
<us-gaap:CommonStockSharesSubscriptions contextRef="Context_As_Of_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember" unitRef="USD" decimals="-6">5000000</us-gaap:CommonStockSharesSubscriptions>
<us-gaap:CommonStockSharesSubscriptions contextRef="Context_As_Of_28-Feb-2011_InvestmentAxis_InvestmentAgreementMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-5">3600000</us-gaap:CommonStockSharesSubscriptions>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_28-Feb-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember">3 years</bcli:WarrantExpiryTerm>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">10 years</bcli:WarrantExpiryTerm>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_31-Jan-2010_SubsidiarySaleOfStockAxis_PrivatePlacementMember">2 year</bcli:WarrantExpiryTerm>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember">1 Year</bcli:WarrantExpiryTerm>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedOneMember_InvestmentAxis_InvestmentAgreementMember">2 Years</bcli:WarrantExpiryTerm>
<bcli:WarrantExpiryTerm contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_WarrantIssuedTwoMember_InvestmentAxis_InvestmentAgreementMember">1 year</bcli:WarrantExpiryTerm>

<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2006_RangeAxis_MaximumMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember" unitRef="USD_per_Share" decimals="2">0.75</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2006_RangeAxis_MinimumMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Jul-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">0.87</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Nov-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="3">0.067</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefFinancialOfficerMember" unitRef="USD_per_Share" decimals="3">0.067</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Dec-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentOptionsExercisePrice>

<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Jan-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">0.20</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentOptionsExercisePrice>


<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="1">0.2</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="0">32</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentOptionsExercisePrice>

<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_30-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="USD_per_Share" decimals="2">0.15</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">0.26</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentOptionsExercisePrice>
<invest:InvestmentOptionsExercisePrice contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerOneMember" unitRef="USD_per_Share" decimals="2">0.29</invest:InvestmentOptionsExercisePrice>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">1000000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefFinancialOfficerMember" unitRef="shares" decimals="0">200000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="shares" decimals="0">166666</bcli:CommonStockPurchasedFromOptionGranted>

<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_31-Jan-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">450000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="0">634999</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="shares" decimals="0">166666</bcli:CommonStockPurchasedFromOptionGranted>

<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="shares" decimals="0">450000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="shares" decimals="0">70000</bcli:CommonStockPurchasedFromOptionGranted>

<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Nov-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerDirectorMember" unitRef="shares" decimals="0">250000</bcli:CommonStockPurchasedFromOptionGranted>




<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember" unitRef="shares" decimals="0">166666</bcli:CommonStockPurchasedFromOptionGranted>

<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_30-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="0">460000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="shares" decimals="0">70000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="shares" decimals="0">4000000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromOptionGranted contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerOneMember" unitRef="shares" decimals="0">2000000</bcli:CommonStockPurchasedFromOptionGranted>
<bcli:CommonStockPurchasedFromIssuanceOfWarrants contextRef="Context_Custom_31-Aug-2008_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_AwardTypeAxis_RestrictedStockMember" unitRef="shares" decimals="0">1000000</bcli:CommonStockPurchasedFromIssuanceOfWarrants>
<bcli:CommonStockPurchasedFromIssuanceOfWarrants contextRef="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfMelamedMember" unitRef="shares" decimals="0">1097215</bcli:CommonStockPurchasedFromIssuanceOfWarrants>
<us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="2">1.40</us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_FYE_31-Dec-2010_RangeAxis_MaximumMember_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="4">0.0314</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_FYE_31-Dec-2010_RangeAxis_MinimumMember_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="4">0.0239</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE_31-Dec-2010_RangeAxis_MaximumMember_StatementEquityComponentsAxis_WarrantMember">P5Y6M</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE_31-Dec-2010_RangeAxis_MinimumMember_StatementEquityComponentsAxis_WarrantMember">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE_31-Dec-2010_RangeAxis_MinimumMember_StatementEquityComponentsAxis_WarrantIssuedOneMember">P1Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE_31-Dec-2010_RangeAxis_MaximumMember_StatementEquityComponentsAxis_WarrantIssuedOneMember">P9Y</us-gaap:FairValueAssumptionsExpectedTerm>
<bcli:CompensationExpensesFilingServices contextRef="Context_Custom_30-Jun-2004_ProductOrServiceAxis_FilingServiceMember" unitRef="USD" decimals="0">26000</bcli:CompensationExpensesFilingServices>
<bcli:CompensationExpensesAmortizationPeriod contextRef="Context_Custom_30-Jun-2004_ProductOrServiceAxis_FilingServiceMember">12 months</bcli:CompensationExpensesAmortizationPeriod>
<bcli:RestrictedSharesPrice contextRef="Context_Custom_28-Feb-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember" unitRef="USD_per_Share" decimals="5">0.00005</bcli:RestrictedSharesPrice>
<bcli:RestrictedSharesPrice contextRef="Context_Custom_30-Apr-2005_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember" unitRef="USD_per_Share" decimals="5">0.00005</bcli:RestrictedSharesPrice>



<bcli:LegalFeesPayable contextRef="Context_As_Of_05-Apr-2009_ProductOrServiceAxis_ChiefTechnologyAdvisorMember" unitRef="USD" decimals="-3">180000</bcli:LegalFeesPayable>
<bcli:LegalFeesPayable contextRef="Context_As_Of_13-Dec-2009_ProductOrServiceAxis_ConvertiblePromissoryNoteToLegalAdvisorMember" unitRef="USD" decimals="-3">217000</bcli:LegalFeesPayable>
<bcli:ConvertibleLoansIntroductionFee contextRef="Context_Custom_20-May-2008_ProductOrServiceAxis_FinancialAdvisorMember" unitRef="USD" decimals="-3">35000</bcli:ConvertibleLoansIntroductionFee>
<us-gaap:InterestAndDebtExpense contextRef="Context_Custom_20-May-2008_ProductOrServiceAxis_FinancialAdvisorMember" unitRef="USD" decimals="-3">36000</us-gaap:InterestAndDebtExpense>
<us-gaap:ConvertibleNotesPayable contextRef="Context_As_Of_05-Mar-2007_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember" unitRef="USD" decimals="-3">150000</us-gaap:ConvertibleNotesPayable>
<us-gaap:ConvertibleNotesPayable contextRef="Context_As_Of_13-Dec-2009_ProductOrServiceAxis_ConvertiblePromissoryNoteToLegalAdvisorMember" unitRef="USD" decimals="-3">135000</us-gaap:ConvertibleNotesPayable>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="Context_As_Of_05-Mar-2007_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember" unitRef="pure" decimals="2">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="Context_As_Of_13-Dec-2009_ProductOrServiceAxis_ConvertiblePromissoryNoteToLegalAdvisorMember" unitRef="pure" decimals="2">0.04</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
<bcli:DebtInstrumentPrincipleWithInterest contextRef="Context_As_Of_27-Jan-2010_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember" unitRef="USD" decimals="-3">189000</bcli:DebtInstrumentPrincipleWithInterest>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_FYE_31-Dec-2009" unitRef="shares" decimals="0">1120000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_27-Jan-2010_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember" unitRef="shares" decimals="0">1016109</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_28-Feb-2010_ProductOrServiceAxis_LegalAdvisorMember" unitRef="shares" decimals="0">402385</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_28-Feb-2011_ProductOrServiceAxis_LegalAdvisorMember" unitRef="shares" decimals="0">445617</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">126111</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<bcli:DistributionServicesPercentage contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="pure" decimals="2">0.10</bcli:DistributionServicesPercentage>
<bcli:DistributionServicesPercentage contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="pure" decimals="2">0.04</bcli:DistributionServicesPercentage>
<bcli:DistributionServicesPercentage contextRef="Context_Custom_28-Feb-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_CashAndCashEquivalentsAxis_CashMember" unitRef="pure" decimals="2">0.06</bcli:DistributionServicesPercentage>
<bcli:DistributionServicesShares contextRef="Context_Custom_31-Mar-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">512600</bcli:DistributionServicesShares>
<bcli:DistributionServicesValue contextRef="Context_Custom_31-Mar-2011_SubsidiarySaleOfStockAxis_PrivatePlacementMember_CashAndCashEquivalentsAxis_CashMember" unitRef="USD" decimals="-3">231000</bcli:DistributionServicesValue>
<bcli:StockOptionExpireDate contextRef="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_GlobalShareOptionPlan2004Member">2014-11-25</bcli:StockOptionExpireDate>
<bcli:StockOptionExpireDate contextRef="Context_FYE_31-Dec-2004_OptionIndexedToIssuersEquityTypeAxis_USStockOptionAndIncentivePlanMember">2015-03-28</bcli:StockOptionExpireDate>
<bcli:StockWarrantExpireDate contextRef="Context_Custom_31-Jul-2007_SubsidiarySaleOfStockAxis_PrivatePlacementMember_InvestmentAxis_InvestmentAgreementMember">2013-11-05</bcli:StockWarrantExpireDate>
<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefFinancialOfficerMember" unitRef="shares" decimals="0">66667</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="Context_As_Of_25-Jul-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">483333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_ServiceProviderMember" unitRef="USD" decimals="-3">15000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrSchorMember" unitRef="USD" decimals="-3">15000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<bcli:StockOptionExpirationTerm contextRef="Context_Custom_31-Oct-2007_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">P10Y</bcli:StockOptionExpirationTerm>
<bcli:StockOptionExpirationTerm contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">P10Y</bcli:StockOptionExpirationTerm>
<bcli:StockOptionExpirationTerm contextRef="Context_Custom_31-Dec-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember">P10Y</bcli:StockOptionExpirationTerm>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_Custom_31-Oct-2007_ProductOrServiceAxis_ScientificAdvisoryBoardMember" unitRef="USD" decimals="-3">67000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_Custom_30-Apr-2009_ProductOrServiceAxis_ChiefTechnologyAdvisorMember" unitRef="USD" decimals="-3">144000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ScientificBoardMember" unitRef="USD" decimals="-3">60000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_Custom_30-Jun-2011_ProductOrServiceAxis_ConsultantsMember" unitRef="USD" decimals="-3">192000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="USD" decimals="-3">24000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses contextRef="Context_1ME_31-Jan-2013_ProductOrServiceAxis_ConsultantsMember" unitRef="USD" decimals="-3">54000</bcli:StockBasedCompensationRecordedInResearchDevelopmentExpenses>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_Custom_31-Aug-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrSchorMember_AwardTypeAxis_RestrictedStockMember">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>

<bcli:PremiumOnWarrantExercisePriceComparedToIssuancePrice contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="pure" decimals="2">1.20</bcli:PremiumOnWarrantExercisePriceComparedToIssuancePrice>
<bcli:PercentageOfWarrantsIssuedOutOfSharesIssuedInPublicOffering contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="pure" decimals="2">0.03</bcli:PercentageOfWarrantsIssuedOutOfSharesIssuedInPublicOffering>
<bcli:WarrantsIssuedToPlacementAgentForPurchaseOfCommonStock contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="shares" decimals="0">493966</bcli:WarrantsIssuedToPlacementAgentForPurchaseOfCommonStock>
<bcli:PlacementAgentFeesAndExpenses contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="USD" decimals="-3">1000000</bcli:PlacementAgentFeesAndExpenses>
<bcli:PercentageOfCorporateFinanceFeeOnGrossProceedsOfOffering contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="pure" decimals="2">0.01</bcli:PercentageOfCorporateFinanceFeeOnGrossProceedsOfOffering>
<bcli:PercentageOfCashFeeOnGrossProceedsOfOffering contextRef="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember" unitRef="pure" decimals="2">0.06</bcli:PercentageOfCashFeeOnGrossProceedsOfOffering>
<bcli:CommonStockFrequencyOfPeriodicIssuance contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_PublicRelationsAdvisorMember">monthly</bcli:CommonStockFrequencyOfPeriodicIssuance>
<bcli:CommonStockPeriodicIssuance contextRef="Context_Custom_31-Jan-2010_ProductOrServiceAxis_PublicRelationsAdvisorMember" unitRef="shares" decimals="0">8333</bcli:CommonStockPeriodicIssuance>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="Context_Custom_31-Aug-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ManagementMember" unitRef="shares" decimals="0">885000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
<bcli:DebtInstrumentInterestRateEffectivePercentageInYearOne contextRef="Context_As_Of_05-Mar-2007_ProductOrServiceAxis_ConvertiblePromissoryNoteToThirdPartyMember" unitRef="pure" decimals="2">0.10</bcli:DebtInstrumentInterestRateEffectivePercentageInYearOne>
<bcli:AmountDueToInvestors contextRef="Context_As_Of_31-Jan-2011" unitRef="USD" decimals="-3">22000</bcli:AmountDueToInvestors>
<bcli:NumberOfOptionsExercisePriceAmended contextRef="Context_Custom_30-Jun-2006_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EmployeeMember" unitRef="shares" decimals="0">270000</bcli:NumberOfOptionsExercisePriceAmended>
<bcli:WarrantsToPurchaseCommonStockSharesRatio contextRef="Context_Custom_31-Jul-2012_SubsidiarySaleOfStockAxis_PublicOfferingMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="2">0.75</bcli:WarrantsToPurchaseCommonStockSharesRatio>
<bcli:NumberOfWarrantsVestOverCourseOfTrails contextRef="Context_FYE_31-Dec-2011_AwardTypeAxis_EnrollmentOfOneThirdOfPatientsMember" unitRef="shares" decimals="0">500000</bcli:NumberOfWarrantsVestOverCourseOfTrails>
<bcli:NumberOfWarrantsVestOverCourseOfTrails contextRef="Context_FYE_31-Dec-2011_AwardTypeAxis_EnrollmentOfAllPatientsMember" unitRef="shares" decimals="0">500000</bcli:NumberOfWarrantsVestOverCourseOfTrails>
<bcli:NumberOfWarrantsVestOverCourseOfTrails contextRef="Context_FYE_31-Dec-2011_AwardTypeAxis_CompletionOfStudyMember" unitRef="shares" decimals="0">500000</bcli:NumberOfWarrantsVestOverCourseOfTrails>
<bcli:StockOptionsVestedPercentage contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="pure" decimals="2">0.33</bcli:StockOptionsVestedPercentage>
<bcli:StockOptionsVestedPercentage contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerOneMember" unitRef="pure" decimals="4">0.3333</bcli:StockOptionsVestedPercentage>
<bcli:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerMember">P36M</bcli:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod>
<bcli:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ChiefExecutiveOfficerOneMember">P36M</bcli:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod>


<us-gaap:QuarterlyFinancialInformationTextBlock contextRef="Context_3ME_31-Mar-2013">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 3&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;The accompanying unaudited interim financial statements have been prepared in a condensed format and include the consolidated financial operations of the Company and its wholly-owned subsidiary as of March 31, 2013 and for the three months then ended, in accordance with accounting principles generally accepted in the United States relating to the preparation of financial statements for interim periods. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2013, are not necessarily indicative of the results that may be expected for the year ended December 31, 2013.&lt;/p&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="Context_Custom_28-Feb-2013_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="USD" decimals="-3">200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<bcli:PercentageOfRoyaltyPaymentIfLicensedProductCoveredByValidClaimOrOrphanDrugStatus contextRef="Context_3ME_31-Mar-2013" unitRef="pure" decimals="2">0.05</bcli:PercentageOfRoyaltyPaymentIfLicensedProductCoveredByValidClaimOrOrphanDrugStatus>
<bcli:PercentageOfRoyaltyPaymentIfLicensedProductNotCoveredByValidClaimOrOrphanDrugStatus contextRef="Context_3ME_31-Mar-2013" unitRef="pure" decimals="2">0.03</bcli:PercentageOfRoyaltyPaymentIfLicensedProductNotCoveredByValidClaimOrOrphanDrugStatus>
<bcli:ValidityOfRoyaltyPaymentNotCoveredByValidClaimOrOrphanDrugStatus contextRef="Context_3ME_31-Mar-2013">P15Y</bcli:ValidityOfRoyaltyPaymentNotCoveredByValidClaimOrOrphanDrugStatus>
<us-gaap:SubsequentEventsDate contextRef="Context_3ME_31-Mar-2013_SubsequentEventTypeAxis_SubsequentEventMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorsAndAdvisoryBoardMember">2013-04-19</us-gaap:SubsequentEventsDate>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="Context_3ME_31-Mar-2013_SubsequentEventTypeAxis_SubsequentEventMember_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorsAndAdvisoryBoardMember" unitRef="shares" decimals="0">760000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<link:loc xlink:type="locator" xlink:href="#Footnote-1_1" xlink:label="lab_Footnote-1_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_1"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_2" xlink:label="lab_Footnote-1_2"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_2"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_3" xlink:label="lab_Footnote-1_3"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_3"/>




<link:loc xlink:type="locator" xlink:href="#Footnote-2_1" xlink:label="lab_Footnote-2_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_1"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_2" xlink:label="lab_Footnote-2_2"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_2"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_3" xlink:label="lab_Footnote-2_3"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_3"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_4" xlink:label="lab_Footnote-2_4"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_4"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_5" xlink:label="lab_Footnote-2_5"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_5"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_6" xlink:label="lab_Footnote-2_6"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_6"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_7" xlink:label="lab_Footnote-2_7"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_7"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_8" xlink:label="lab_Footnote-2_8"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_8"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_9" xlink:label="lab_Footnote-2_9"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_9"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_10" xlink:label="lab_Footnote-2_10"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_10"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_11" xlink:label="lab_Footnote-2_11"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_11"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_12" xlink:label="lab_Footnote-2_12"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_12"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_13" xlink:label="lab_Footnote-2_13"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_13"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_14" xlink:label="lab_Footnote-2_14"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_14"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_15" xlink:label="lab_Footnote-2_15"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_15"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_16" xlink:label="lab_Footnote-2_16"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_16"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_17" xlink:label="lab_Footnote-2_17"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_17"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_18" xlink:label="lab_Footnote-2_18"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_18"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_19" xlink:label="lab_Footnote-2_19"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_19"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_20" xlink:label="lab_Footnote-2_20"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_20"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_21" xlink:label="lab_Footnote-2_21"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_21"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_22" xlink:label="lab_Footnote-2_22"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_22"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_23" xlink:label="lab_Footnote-2_23"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_23"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_24" xlink:label="lab_Footnote-2_24"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_24"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_25" xlink:label="lab_Footnote-2_25"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_25"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_26" xlink:label="lab_Footnote-2_26"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_26"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_27" xlink:label="lab_Footnote-2_27"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_27"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_28" xlink:label="lab_Footnote-2_28"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_28"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_29" xlink:label="lab_Footnote-2_29"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_29"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_30" xlink:label="lab_Footnote-2_30"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_30"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_31" xlink:label="lab_Footnote-2_31"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_31"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_32" xlink:label="lab_Footnote-2_32"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_32"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_33" xlink:label="lab_Footnote-2_33"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_33"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_34" xlink:label="lab_Footnote-2_34"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_34"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_35" xlink:label="lab_Footnote-2_35"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_35"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_6" xlink:label="lab_Footnote-1_6"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_6"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_7" xlink:label="lab_Footnote-1_7"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_7"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_8" xlink:label="lab_Footnote-1_8"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_8"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_9" xlink:label="lab_Footnote-1_9"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_9"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_10" xlink:label="lab_Footnote-1_10"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_10"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_11" xlink:label="lab_Footnote-1_11"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_11"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_12" xlink:label="lab_Footnote-1_12"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_12"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_13" xlink:label="lab_Footnote-1_13"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_13"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_14" xlink:label="lab_Footnote-1_14"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_14"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_15" xlink:label="lab_Footnote-1_15"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_15"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_16" xlink:label="lab_Footnote-1_16"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_16"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_17" xlink:label="lab_Footnote-1_17"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_17"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_18" xlink:label="lab_Footnote-1_18"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_18"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_19" xlink:label="lab_Footnote-1_19"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_19"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_20" xlink:label="lab_Footnote-1_20"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_20"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_21" xlink:label="lab_Footnote-1_21"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_21"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_22" xlink:label="lab_Footnote-1_22"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_22"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_23" xlink:label="lab_Footnote-1_23"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_23"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_24" xlink:label="lab_Footnote-1_24"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_24"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_25" xlink:label="lab_Footnote-1_25"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_25"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_26" xlink:label="lab_Footnote-1_26"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_26"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_27" xlink:label="lab_Footnote-1_27"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_27"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_28" xlink:label="lab_Footnote-1_28"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_28"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_29" xlink:label="lab_Footnote-1_29"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_29"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_30" xlink:label="lab_Footnote-1_30"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_30"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_31" xlink:label="lab_Footnote-1_31"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_31"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_32" xlink:label="lab_Footnote-1_32"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_32"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_33" xlink:label="lab_Footnote-1_33"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_33"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_34" xlink:label="lab_Footnote-1_34"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_34"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:label="Footnote-1">Out of the which, cash flows used in discontinued operating activities of $36, cash flows used in discontinued investing activities of $16 and cash flows provided in discontinued financing activities of $57, relating to the period from inception to March 31, 2004, is unaudited.</link:footnote>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:label="Footnote-2">Represents an amount less than $1.</link:footnote>


<link:loc xlink:type="locator" xlink:href="#Footnote-3_1" xlink:label="lab_Footnote-3_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-3" xlink:from="lab_Footnote-3_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:label="Footnote-3">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-4_1" xlink:label="lab_Footnote-4_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-4" xlink:from="lab_Footnote-4_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-4" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-5_1" xlink:label="lab_Footnote-5_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-5" xlink:from="lab_Footnote-5_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-5" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-6_1" xlink:label="lab_Footnote-6_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-6" xlink:from="lab_Footnote-6_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-6" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-7_1" xlink:label="lab_Footnote-7_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-7" xlink:from="lab_Footnote-7_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-7" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-8_1" xlink:label="lab_Footnote-8_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-8" xlink:from="lab_Footnote-8_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-8" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-9_1" xlink:label="lab_Footnote-9_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-9" xlink:from="lab_Footnote-9_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-9" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-10_1" xlink:label="lab_Footnote-10_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-10" xlink:from="lab_Footnote-10_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-10" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-11_1" xlink:label="lab_Footnote-11_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-11" xlink:from="lab_Footnote-11_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-11" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-12_1" xlink:label="lab_Footnote-12_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-12" xlink:from="lab_Footnote-12_1"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-12" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Footnote-12_1" xlink:to="Footnote-1" order="2.0"/>
</link:footnoteLink>


<xbrli:context id="Context_As_Of_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ProfDanielOffenConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-12-31</xbrli:instant></xbrli:period></xbrli:context>
	<bcli:AdditionalSharesApprovedForServices contextRef="Context_As_Of_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember" unitRef="shares" decimals="0">400000</bcli:AdditionalSharesApprovedForServices>
<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:ConsultantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember" unitRef="shares" decimals="0">216000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>

<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorOneMember" unitRef="shares" decimals="0">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm contextRef="Context_Custom_17-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_LeaderUnderwriters1993LtdMember">30 month</us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm>
<xbrli:context id="Context_1ME_31-Mar-2013_ProductOrServiceAxis_LegalAdvisorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:LegalAdvisorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_1ME_31-Mar-2013_ProductOrServiceAxis_ServiceProviderMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ServiceProviderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_As_Of_28-Feb-2011_InvestmentAxis_InvestmentAgreementMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="invest:InvestmentAxis">bcli:InvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-02-28</xbrli:instant></xbrli:period></xbrli:context>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_Custom_30-Jun-2009_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="shares" decimals="0">483333</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_1ME_31-Mar-2013_ProductOrServiceAxis_LegalAdvisorMember" unitRef="shares" decimals="0">193696</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<xbrli:context id="Context_1ME_31-Mar-2013_ProductOrServiceAxis_ConsultantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConsultantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_1ME_31-Mar-2013_ProductOrServiceAxis_ConsultantsMember" unitRef="shares" decimals="0">216000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_1ME_31-Mar-2013_ProductOrServiceAxis_ServiceProviderMember" unitRef="shares" decimals="0">400000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<xbrli:context id="Context_1ME_31-Jan-2013_ProductOrServiceAxis_ConsultantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:ConsultantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_1ME_31-Jul-2012_ProductOrServiceAxis_PlacementAgentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">bcli:PlacementAgentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2012-07-01</xbrli:startDate><xbrli:endDate>2012-07-31</xbrli:endDate></xbrli:period></xbrli:context>



<bcli:UnitSoldComprisedOfOneShareAndOneWarrant contextRef="Context_Custom_28-Feb-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">1894808</bcli:UnitSoldComprisedOfOneShareAndOneWarrant>
<bcli:UnitSoldComprisedOfOneShareAndOneWarrant contextRef="Context_Custom_31-Aug-2005_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitRef="shares" decimals="0">1250000</bcli:UnitSoldComprisedOfOneShareAndOneWarrant>
<us-gaap:SubsequentEventsDate contextRef="Context_3ME_31-Mar-2013">2013-04-18</us-gaap:SubsequentEventsDate>
<us-gaap:StockholdersEquityReverseStockSplit contextRef="Context_3ME_31-Mar-2013">between 1-for-10 and 1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:HadasitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-03</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="shares" decimals="0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<bcli:CommonStockExercisePrice contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="USD_per_Share" decimals="5">0.00005</bcli:CommonStockExercisePrice>
<us-gaap:SubsequentEventsDate contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember_SubsequentEventTypeAxis_SubsequentEventMember">2013-04-13</us-gaap:SubsequentEventsDate>
<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">bcli:MrIsraeliMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="shares" decimals="0">166666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<bcli:CommonStockExercisePrice contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="USD_per_Share" decimals="5">0.00005</bcli:CommonStockExercisePrice>
<us-gaap:SubsequentEventsDate contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_MrIsraeliMember_SubsequentEventTypeAxis_SubsequentEventMember">2013-04-13</us-gaap:SubsequentEventsDate>
<xbrli:context id="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="shares" decimals="0">460000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<bcli:CommonStockExercisePrice contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="USD_per_Share" decimals="2">0.15</bcli:CommonStockExercisePrice>
<us-gaap:SubsequentEventsDate contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_DirectorMember_SubsequentEventTypeAxis_SubsequentEventMember">2013-04-19</us-gaap:SubsequentEventsDate>
<us-gaap:PaymentsToAcquireShortTermInvestments contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:PaymentsToAcquireShortTermInvestments>
<xbrli:context id="Context_0ME_24-Dec-2009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-12-01</xbrli:startDate><xbrli:endDate>2009-12-24</xbrli:endDate></xbrli:period></xbrli:context>
	<bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses contextRef="Context_FYE_31-Dec-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_EldadMelamedAndDanielOffenConsultantsMember" unitRef="USD" decimals="-3">220000</bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses contextRef="Context_FYE_31-Dec-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ProfDanielOffenConsultantMember" unitRef="USD" decimals="-3">192000</bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses contextRef="Context_3ME_31-Mar-2013_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember" unitRef="USD" decimals="-3">54000</bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses>
<bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses contextRef="Context_FYE_31-Dec-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_ConsultantsMember" unitRef="USD" decimals="-3">162000</bcli:StockBasedCompensationRecordedAsResearchDevelopmentExpenses>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2013" unitRef="shares" decimals="0">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentWarrantsExercisePrice>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_30-Apr-2010_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="shares" decimals="0">33334</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentWarrantsExercisePrice>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_30-Apr-2012_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="shares" decimals="0">33334</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<bcli:WarrantsIssuedToPurchaseOfCommonStock contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="shares" decimals="0">33334</bcli:WarrantsIssuedToPurchaseOfCommonStock>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_30-Jun-2011_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAxis_HadasitMember" unitRef="USD_per_Share" decimals="5">0.00005</invest:InvestmentWarrantsExercisePrice>
<xbrli:context id="Context_As_Of_06-May-2013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-05-06</xbrli:instant></xbrli:period></xbrli:context>
	</xbrli:xbrl>
